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Zusammenfassung 
Die regulierte Exozytose von Neurotransmittern und vieler Hormone erfolgt an 
spezialisierten sekretorischen Komplexen über Ca2+-vermittelte Fusion sekretorischer 
Vesikel mit der Plasmamembran. Der molekulare Mechanismus der 
Neurotransmitter- und Hormonausschüttung steht im Focus intensiver Forschung. 
Viele Proteine, die eine Rolle spielen könnten in der regulierten Form der Exozytose, 
wurden isoliert. CAPS (calcium-activator protein of secretion) ist ein zytosolisches 
Protein, das mit large dense core Vesikeln assoziiert ist und an ihrer Sekretion 
beteiligt ist. Säugetiere exprimieren zwei CAPS-Isoformen mit ähnlicher 
Domain-Struktur, die unter anderem eine Munc13 Homologie Domaine (MHD) 
beinhalten, die für das „Priming“ von sekretorischen Vesikeln verantwortlich sein soll. 
Wo CAPS im sekretorischen Prozess agiert ist noch unklar. Wir untersuchten die 
Sekretion von CAPS-2 KO Chromaffinzellen, die eine ähnliche Sekretion zeigten wie 
Wildtyp-Zellen. Anschließend untersuchten wir die Sekretion von Chromaffinzellen in 
denen beide CAPS-Gene deletiert wurden mit dem Ziel die Funktion von CAPS in 
der regulierten Exozytose zu entschlüsseln. 
Die Deletion beider CAPS Isoformen führte zu einer Reduktion des „rapidly 
releasable pools“ der Chromaffingranulen und des „sustained release“ bei weiterer 
Stimulation. Die ähnliche Verteilung von LDCV in CAPS DKO und Wildtypzellen 
schließt die Möglichkeit aus, dass die verminderte Sekretion in CAPS DKO Zellen 
durch einen Defekt im „docking“ der LDCV hervorgerufen wird. 
Doppel-Flash-Experimente zeigen, dass nach starker sekretorischer Aktivität in 
CAPS DKO Zellen im Vergleich zu Wildtyp-Zellen, die Wiederherstellung des RRP 
stark reduziert ist, aber das Auffüllen des SRP normal bleibt. Die Calcium-Sensitivität 
der Exozytose wurden durch „calcium ramp“ Experimente und die Fusionskinetik 
durch Einzelspikeanalyse untersucht. Durch die Deletion von CAPS wurde die 
Calcium-Sensitivität oder die Kinetik der Fusion der einzelnen Vesikel während der 
Sekretion nicht verändert. 
Sowohl CAPS1 als auch CAPS2 können die Sekretion in Zellen, denen beide 
CAPS-Isoformen fehlen, wiederherstellen. Zusätzlich kann durch die konstitutiv 
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offene Form von Syntaxin der Verlust des Readily releasable LDCV Pools bei Verlust 
von CAPS wiederhergestellt werden. Munc13-1 jedoch, ein Priming-Protein, das die 
Umformung von Syntaxin in die offene Konformation vereinfacht, hat keinen Effekt. 
Wir schließen daraus, dass CAPS für das Auffüllen und/oder die Erhaltung des 
rapidly releasable Pools benötigt wird und eher stromabwärts von Munc13s wirkt. 
Eine funktionelle Interaktion zwischen diesen beiden Proteinen scheint während des 
gesamten LDCV-Priming Prozesses nötig zu sein, einschließlich der Öffnung von 
Syntaxin. 
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Abbreviations 
[Ca2+]i Intracellular calcium concentration 
ATP Adenosine Triphosphate  
BHK Syrian Hamster Kidney  
BoNT Botulinum Toxin  
Bp Base pair 
BSA Bovine Serum Albumin  
C. elegans Caenorhabditis elegans  
Ca2+ Calcium 
cAMP Cyclic adenosine monophosphate  
CAPS Calcium-dependent activator protein for secretion  
Cm Membrane capacitance 
DAG Diacylglycerol  
dATP Deoxyriboadenosine Triphosphate  
DEPC Diethylpyrocarbonate  
DMEM Dulbecco’s Modified Eagle’s Medium  
DMSO Dimethylsulphoxide  
DNA Deoxyribonuleotide   
dNTP Desoxyribonucleotide 
DKO  CAPS-1/CAPS-2 double knock-out 
DPTA 1,3-Diamino-2-propanol-N,N,N,N-tetraacetic acid 
DTT 1,4-Dithiotheritol  
ECL Enhanced Chemiluminescence  
EDTA Ethylene Diamine Tetra-Acetic Acid  
EGFP Enhanced Green Fluorescent Protein 
EGTA Ethylene bis-(oxyethylenenitrilo)-tetraacetic acid 
EM Electron Microscope  
ER Endoplasmic Reticulum  
FCS Fetal Calf Serum  
fF Femtofarad 
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Fig Figure  
GA Golgi apparatus  
GFP Green Fluorescent Protein  
GTP Guanidine Triphosphate 
H2O Water 
HEPES 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid  
IRES Internal Ribosome Entry Site  
Kd Dissociation constant 
KDa Kilo Dalton 
KHz Kilohertz 
LDCV Large Dense-Core vesicle  
MHD Munc Homology Domain  
mOsm Milliosmol 
MSD Mean Square Displacement  
n Number of measured cells 
N Number of measured mice 
NGS Normal Goat Serum  
NP-EGTA Nitrophenyl-EGTA 
NPY Neuro-peptide Y 
nS nano Siemens 
NSF N-ethylmaleimide sensitive factor  
PBS Phosphate Buffered Saline  
PC-12 cells Pheochromocytoma cells 
PCR Polymerase Chain Reaction  
pH Potential hydrogen 
PKA Protein kinase A  
PKC Protein kinase C  
PM Plasma Membrane  
PMA Phorbol-12-myristate-13-acetate  
PV Polyvirus  
Rm Membrane resistance (resistance of the cell) 
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RNA Ribonucleic acid  
RNase Ribonuclease  
RPM Revolutions per minute 
RRP Rapidly-releasable pool 
Rs Series Resistance (pipette resistance) 
RT Room Temperature  
S Siemens 
SDS Sodium Dodecyl Sulfate   
SEM Standard Error of Mean  
SFV Semliki Forest Virus  
SNAP-25 Synaptosome Associated Protein of 25 kD  
SNARE Soluble NSF Attachment Protein Receptor  
SRP Slowly releasable pool 
SV Synaptic Vesicle 
TAE-Buffer Tris acetate EDTA buffer 
TeNt Tetanus Toxin  
TGN Trans-Golgi network 
Tris 2-Amino-2(hydroxymethyl)-1,3-propanediol 
U Voltage 
UPP Unprimed Pool  
UV Ultra violet 
VAMP Vesicle Associated Membrane Protein 
α-SNAP α-Soluble NSF Attachment Protein  
µL Microliter 
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1. Introduction 
1.1 Regulated exocytosis and neurotransmitter release 
Exocytosis is an important pathway for the movement of substances across 
membranes. Two distinct pathways use exocytosis to release materials into the 
extracellular space, a constitutive exocytotic pathway and a non-constitutive 
regulated exocytotic pathway. Constitutive exocytosis, present in all eukaryotic cells, 
mediates the transport of soluble proteins and other materials from Golgi complex to 
the cell surface, supplies newly synthesized lipid and membrane protein to the 
plasma membrane, and provides nutrients to cells. It is essential for the maintenance 
and reconstitution of cells. There is no evidence that constitutive exocytosis requires 
a stimulatory signal. 
Regulated exocytosis is present in some more specialized cells, such as neurons 
and neuroendocrine cells. In contrast to constitutive exocytosis, regulated exocytosis 
requires a stimulus to induce secretion. This stimulus varies according to cell type. 
The secretory products for regulated exocytosis are concentrated and packed into 
specialized membrane-bound organelles, secretory granules, and these granules can 
be stored for long periods of time and thus can form a large intracellular pool of 
mature secretory products (Burgess and Kelly, 1987). Regulated exocytosis 
constitutes the basis of neurotransmission, and has been extensively studied in 
neurons and neuroendocrine cells. Two types of secretory granules are found, which 
differ in their contents. Vesicles containing classical neurotransmitters, which are 
released rapidly at synapses, are small clear vesicles (SCVs), while vesicles 
containing neuropeptides and neurotransmitters, exhibiting large dense core under 
electron microscope, are termed large dense core vesicles (LDCVs). LDCVs are 
larger than SCVs. Both SCVs and LDCVs are present in neurons and 
neuroendocrine cells. 
Ca2+ evoked neurotransmitter release is temporally and spatially tightly regulated. 
According to the results from morphological studies, vesicles in the synapse are 
restricted to designated release sites at so-called active zones. Only a fraction of the 
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vesicles contacting the plasma membrane are readily releasable (Sudhof, 1995). In 
neuroendocrine cells such as adrenal chromaffin cells and pancreatic β cells, there is 
no active zone, but a fraction of vesicles also are found in close apposition to the 
plasma membrane. When an action potential occurs, Ca2+ influx through 
voltage-gated Ca2+ channel stimulates the fusion of vesicles containing 
neurotransmitter with the plasma membrane. Released neurotransmitters diffuse 
across the synaptic cleft and bind to postsynaptic receptors to produce a new 
electrical signal. This excitation coupled exocytosis is a very fast process occurring in 
less than 1ms (Borst and Sakmann, 1996). In cerebellar synapses, the delay 
between the Ca2+ influx and postsynaptic response is 60 µs (Sabatini and Regehr, 
1996); in the giant terminals of the calyx of Held it is 300 µs (Bollmann et al., 2000). 
Ca2+ triggered secretion in adrenal chromaffin cells is slower than that in neurons and 
occurs within 1-20 ms (Voets, 2000). This rapid and precisely regulated exocytosis is 
tightly controlled by a sophisticated regulatory protein machinery which has been 
intensively studied.  
The work presented here is focused on the role of CAPS (Ca2+-dependent activator 
protein for secretion) in the regulated exocytosis of mouse chromaffin cells. CAPS is 
a cytosolic protein that associates with large dense core vesicles and is involved in 
their secretion. In this study, the role of CAPS in regulated exocytosis of mouse 
chromaffin cells was investigated using genetic and electrophysiological methods. 
1.2 Key steps of regulated exocytosis  
Before vesicles arrive at their destination and fuse with the membrane, they must 
undergo a series of maturation steps (Fig. 1). Synaptic vesicles bud from the early 
endosome, and are then filled with neurotransmitter by vesicular transporters which 
are driven by a proton gradient across the vesicular membrane (Tooze et al., 2001). 
Packed vesicles are delivered to the plasma membrane and cluster at the active 
zone. Vesicles are eventually tethered and held close to the membrane, which is 
called docking. Vesicles go through further maturation steps to become releasable 
and then are available for release when triggered by a rise in [Ca2+]i. The maturation 
to the releasable state is referred to as priming. Finally vesicles fuse with the 
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membrane upon an increase of the intracellular calcium. Secretory granules in 
chromaffin cells originate from the Trans-Golgi network (Burgoyne and Morgan, 
2003). The uptake of the catecholamine into secretory granules relies on active 
transport driven by a proton gradient. Prior to exocytosis, secretory granules in 
chromaffin cells undergo the same sequential steps as synaptic vesicles. After 
exocytosis, vesicles can be retrieved by endocytosis via several pathways. 
 
 
 
Figure 1. A general depict of vesicular recycling. (Modified from (Brose et al., 2000)) 
 
1.2.1 Docking 
Docked vesicles are traditionally defined as those vesicles that appear closely 
apposed to the plasma membrane in electron micrographs (Verhage and Sorensen, 
2008). Due to the definition of docking, docking has been studied mainly by electron 
microscopy. In neurons, vesicles are clearly visualized under the electron microscope 
and found accumulated at active zones. In chromaffin cells, secretory granules 
containing neuropeptides are easily identified by their large dense core. These 
vesicles distribute along the plasma membrane of the whole cell. The distribution of 
vesicles with respect to the plasma membrane is typically determined to examine 
docked vesicles. There are two different criteria to determine the docked vesicles. (1) 
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Vesicles within a distance from the plasma membrane are docked vesicles; normally 
this certain distance is smaller or equal to the average of a vesicle radius (Borisovska 
et al., 2005). (2) Vesicles in direct contact with the plasma membrane are docked 
vesicles, which means there is no measurable distance between the docked vesicles 
and the plasma membrane (Schikorski and Stevens, 2001). Both methods have flaws. 
The first method sets a large range for counting docked vesicles thus may 
overestimate the number of docked vesicles. The second method is quite stringent 
and thus underestimates the number of docked vesicles. The cumulative distance 
distribution of vesicles to the plasma membrane is used to estimate docked vesicles. 
If there was an augmentation or defect in docking, the plot of cumulative distance 
distribution will show a deviation at short distances from plasma membrane. Recently 
it has been suggested that conventional chemical fixation for electron microscopy 
might change the cell ultrastucture and cause modification of vesicle localization 
(Hammarlund et al., 2007). High-pressure freezing has been developed to improve 
sample preparation. The specimen is frozen by liquid nitrogen under high pressure 
(200 MPa) to avoid ice crystal formation in the cytoplasm (Studer et al., 2008). 
Cryofixation at high-pressure better preserves cell ultrastucture and circumvents 
artefacts caused by conventional chemical fixation. Electron microscopy combined 
with high-pressure freezing might allow high resolution imaging of vesicles in a 
close-to-native state. Its application has begun to change our view of the docked 
state. Although electron microscopy provides helpful information for investigation of 
docking, it delivers a static picture of vesicle distribution. Dynamic information of 
concerning changes in docking is more difficult to acquire. Total internal reflection 
fluorescence (TIRF) microscopy allows one to track vesicle movement near the target 
membrane. Vesicles are labelled by fluorescent cargo or fluorescent dye. As TIRF 
microscopy selectively excites the fluorophores in cellular environment very near to a 
solid surface (within ≤100 nm) (Axelrod, 2001), only vesicles that are very close to 
the membrane can be visualized. Docked vesicles are within this range, as they 
appear to be tethered to the plasma membrane (Toonen et al., 2006). Analysis of 
movements and mobility of vesicles may allow quantification of vesicles docking in 
living cells (Nofal et al., 2007). However TIRF microscopy can only track a fraction of 
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vesicles in a cell depending on how and what percent of vesicles are effectively 
labelled by fluorescent cargo or fluorescent dye. This makes it difficult to compare the 
results from electron microscopy and TIRF microscopy. TIRF microscopy 
supplements electron microscopy by giving dynamic information about single vesicle 
movement at the plasma membrane. 
1.2.2 Priming 
When [Ca2+]i is suddenly increased from resting level (~ 100 nM) to tens of µM, 
vesicles are released as a rapid exocytotic burst. The exocytotic burst represents the 
secretion from primed vesicles in a readily releasable pool. If the calcium 
concentration remains high, releasable pools are rapidly emptied. However the 
number of vesicles in the readily releasable pool calculated from the amplitude of 
exocytotic burst, are much fewer than that of the docked vesicles recognized in 
electron micrographs (Steyer et al., 1997). This indicates that only a fraction of 
docked vesicles are fully mature and readily releasable. This is the primed pool of 
vesicles.  
Upstream of the readily releasable pool is a Depot pool (DP) and the docked but 
unprimed pool (UPP). Vesicles from the Depot pool undergo docking to enter a 
docked but unprimed state, then prime into the readily releasable pool. The readily 
releasable pool can be further divided into a rapidly releasable pool (RRP) and a 
slowly releasable pool (SRP) distinguished by different release kinetics. Capacitance 
measurements combined with flash photolysis of caged calcium compounds are used 
to dissect the releasable pools. Vesicle fusion induces an increase of plasma 
membrane area which can be detected electrically as an increase of cell capacitance. 
Capacitance measurements allow high temporal resolution, and thus allow the 
accurate kinetic analysis of vesicle fusion. As Ca2+ is the messenger to trigger the 
exocytosis and the secretory rate is related to [Ca2+]i, different manipulations to 
increase [Ca2+]i can affect the time course of exocytosis (Sorensen, 2004). Photolysis 
of Ca2+-caged compounds provide a good way to control [Ca2+]i. Ca2+ bound to the 
calcium caging compounds, NP-EGTA (Nitrophenyl-EGTA) or DMN (DM-Nitrophen), 
is perfused into cells through a glass patch pipette. Upon UV illumination, the affinity 
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of NP-EGTA or DMN for Ca2+ is greatly reduced in a few microseconds. The 
intracellular free calcium concentration is quickly elevated throughout the cell. Using 
calcium-sensitive fluorescence dyes, [Ca2+]i can be measured in real time before and 
after UV flash. In such a flash experiment shown in Fig. 2, [Ca2+]i is raised from a 
base level of about 300 nM to near 20 µM in a bovine chromaffin cell, secretion is 
measured as the increase of capacitance, and released catecholamines are detected 
by amperometry. The capacitance trace can be fit as the sum of two exponentials and 
a linear component. The exponential component with a fast time constant, called the 
fast burst, represents the secretion from RRP; the slower exponential component is 
the slow burst and represents the secretion from SRP. The amplitudes of the fast and 
slow bursts estimate the size of RRP and SRP respectively. Voets showed that the 
RRP and SRP sizes are dependent upon the preflash [Ca2+]i thus indicating that the 
priming process is Ca2+-dependent (Voets, 2000). After the readily releasable pool is 
depleted, unprimed vesicles under sustained high [Ca2+]i go through the priming 
reaction and then fuse with the plasma membrane. Thus the linear sustained phase 
following the fast exocytotic burst reflects priming, under high intracellular calcium 
concentration. 
According to the electrophysiological data, priming is defined as a post-docking step, 
which results in vesicles becoming fusion competent. However studies from 
permeabilized PC12 cells indicate that Mg-ATP is necessary to support sustained 
secretion (Hay and Martin, 1992). This may indicate that the priming is ATP 
dependent. However these results come from biochemical experiments which are too 
slow to distinguish priming from release, and are rate-limited by several factors, for 
example, PIP2 and SNARE proteins (Hay and Martin, 1993; Lang et al., 2002). To 
study the priming process, a high time resolution method is needed, which is best 
achieved by whole cell capacitance measurements.  
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Figure 2. Vesicle pools and flash 
responses.  
A. A typical flash photolysis response 
cooperated with carbon fibre 
microelectrode. Upper is a step 
increase of [Ca2+]i from 300 nM (basic 
level) to 20 µM. Middle is the increase 
of membrane capacitance. Lower is 
the related change of amperometric 
signal.  
B. Vesicles are depicted in four 
different states. In time sequence are 
Depot pool, UPP (red, unprimed 
vesicles pool), SRP (green, solid 
release pool) and RRP (yellow, ready 
release pool). (Modified from (Rettig 
and Neher, 2002)) 
 
 
1.2.3 Ca2+ triggering 
Ca2+ has multiple roles in neurotransmitter release not only accelerating the 
recruitment of vesicles (priming) but also triggering the fusion of vesicles. Under 
physiological circumstances, neurotransmitter release is evoked by Ca2+ influx 
through the voltage-dependent Ca2+ channels during membrane depolarization. 
Depolarization studies in neuroendocrine cells show that short depolarizations induce 
the release of fewer vesicles than do long depolarizations, and indicate that there is 
an immediately releasable pool (Horrigan and Bookman, 1994; Moser and Neher, 
1997). Comparison of the results obtained from depolarization and flash photolysis 
experiments reveal that only a small fraction of the vesicles in the RRP can be rapidly 
released in response to the brief depolarization (Voets et al., 1999). This indicates 
that vesicles in immediately releasable pool (IRP) exhibit fast fusion rates due to their 
close proximity to Ca2+ channels, rather than to a difference of fusion competence 
state or Ca2+ sensitivity. Depolarization induces Ca2+ influx though the 
voltage-dependent Ca2+ channels and produces a complicated spatial distribution of 
Ca2+ signal. Peak [Ca2+]i within the microdomain of 10-20 nm around the Ca2+ 
channel can reach 100 µM or more in less than 100 µs after the channel has opened, 
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with a distance of 100-200 nm the peak values rise slowly and are only in the 
micromolar or tens of micromolar range (Neher, 1998). Because at different distances 
from Ca2+ channels, different calcium signals occur. Vesicles which are equally 
competent to fuse show different fusion rates. To circumvent this complication, and to 
establish the relationship between vesicle fusion rates and [Ca2+]i, photolysis of 
caged Ca2+ is used to produce spatially uniform [Ca2+]i elevations which are 
measured fluometrically. Release rates are estimated on the basis of capacitance 
measurements. Two different methods are used to elevate [Ca2+]i, UV flash, and 
ramp experiments, respectively. In flash experiments, a stepwise increase of [Ca2+]i 
triggers secretion, and time constants of the SRP and the RRP are referred as the 
secretory rates which are correlated to the postflash [Ca2+]i with a three to four power 
relationship (Voets, 2000). In ramp experiments, [Ca2+]i is elevated slowly by applying 
a series of illuminations altering between 350 nm and 380 nm, Ca2+-dependence of 
the secretory rate is determined (Sorensen et al., 2001). Both flash and ramp 
experiments can be used to investigate the Ca2+-dependence of secretion, however 
ramp experiments slowly elevate [Ca2+]i from nM range to tens of µM thus allowing 
determination of the [Ca2+]i threshold of secretion. 
1.2.4 Fusion 
Vesicle fusion with the plasma membrane is the final step of secretion. Fusion of lipid 
bilayers starts with close proximity of vesicles and plasma membrane. The boundary 
between the hydrophilic and hydrophobic portion of the bilayer is destabilized. The 
membranes form non-bilayer transition states and initiate the formation of an 
aqueous fusion pore (Jahn et al., 2003). The fusion pore was first investigated in 
mast cells by using quick-freezing and freeze-fracture techniques. It is a 
narrow-necked pore, 0.1 micrometer in diameter connecting the granule interior and 
the extracellular space (Chandler and Heuser, 1980). Electrophysiological studies in 
mast cells examined the conductance of fusion pore and revealed that the membrane 
fusion begins with the formation of a fusion pore and later the fusion pore dilates to 
allow the release of vesicle content (Breckenridge and Almers, 1987). 
Electrochemical methods are available to directly detect the transmitters released 
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from single cells (Leszczyszyn et al., 1990). Studies in chromaffin cells show that 
carbon-fibre electrodes are sensitive enough to detect catecholamines released from 
single granules and statistical analysis of these signals suggest quantal release of 
neurotransmitter. It is also shown that sometimes a small “foot” signal occurs 
preceding a large amperometrical spike, which may reflect the slow leak of 
catecholamine molecules out of narrow fusion pore before complete pore expansion 
and exocytosis (Chow et al., 1992). Whether the size of fusion pore can regulate the 
quantal neurotransmitter release is still under debate.  
Electrochemical methods can be applied in various secretory cells. Patch-clamp 
experiments combined with electrochemical measurements in mouse mast cells 
indicate that fusion of secretory vesicles with plasma membrane does not always 
happen as an all-or-none event (Alvarez de Toledo et al., 1993). Measurements in 
chromaffin cells indicate that occasionally the narrow fusion pore allows complete 
transmitter release without full fusion of the vesicle with the plasma membrane 
(Albillos et al., 1997), which is termed as “kiss and run”. The mechanism controlling 
“kiss and run” or full fusion is under investigation. 
1.3 Molecular mechanism of exocytosis 
The molecular mechanism of exocytosis has been intensively investigated in recent 
years, and has lead to the identification of many proteins involved in neurotransmitter 
release, for example SNARE proteins and SM proteins (Rizo and Rosenmund, 2008). 
SNARE complexes are the core machinery of exocytosis which not only execute the 
fast membrane fusion in synapses, but also drive much slower secretion in other 
tissues (Dietl et al., 2001; Sollner et al., 1993). To allow fast and accurate synaptic 
transmission, additional proteins are required to regulate speed, accuracy and 
plasticity at synapses (Wojcik and Brose, 2007). Munc13 is a priming factor for 
vesicle fusion (Ashery et al., 2000). CAPS was originally characterized as a brain 
cytosolic factor which reconstitutes regulated secretion in permeable neuroendocrine 
cells (Walent et al., 1992). In this work, the major interest is the role of CAPS in 
secretion. 
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1.3.1 SNARE proteins 
SNARE proteins form a superfamily of small proteins which are conserved from yeast 
to humans and govern most types of intracellular membrane traffic (Bonifacino and 
Glick, 2004). There are 25 members of SNARE proteins found in Saccharomyces 
cerevisiae, 36 members in humans and 54 members in Arabidopsis thaliana. All 
SNAREs share an evolutionarily conserved stretch of 60-70 amino acids called the 
SNARE motif (Jahn and Scheller, 2006). Most SNAREs have variable domains 
positioned N-terminal to the SNARE motif and a single transmembrane domain 
connected with the SNARE motif by a short linker at the C-terminal (Jahn and 
Scheller, 2006). The SNARE motif contains periodically aligned hydrophobic residues 
and mediates the assembly of SNARE complex. 
Different sets of SNAREs present in the two opposing membranes form a trimeric 
complex which is essential for vesicle fusion (Sollner et al., 1993). This leads to a 
functional classification of SNARE proteins as v-SNAREs (vesicle-membrane 
SNAREs) and t-SNAREs (target-membrane SNAREs) on the basis of their different 
localizations. Vesicle exocytosis in neurons and neuroendocrine cells is carried out 
by the v-SNARE synaptobrevin-2 (also known as VAMP 2) with syntaxin-1 and 
SNAP-25 as t-SNAREs on the target membrane. The three proteins, in a 1:1:1 
stoichiometry, form a helical coil-coiled trans-SNARE complex which consists four 
α-helices, one from synaptobrevin-2, one from syntaxin-1 and two from SNAP-25 
(Chapman et al., 1994). X-ray crystallography revealed that there are 16 highly 
conserved leucine-zipper-like layers of interacting amino acid side chains at the 
centre of the four-helix bundle (shown in Fig. 3; (Sutton et al., 1998)). These layers 
are largely hydrophobic except the central ionic “0” layer which contains three highly 
conserved glutamine (Q) residues and one highly conserved arginine (R) residue 
(Fasshauer et al., 1998b). This result leads to a reclassification of v-SNAREs and 
t-SNAREs as Qa-, Qb-, Qc- and R-SNAREs. The functional trans-SNARE complex 
mediates membrane fusion requiring one each of Qa-, Qb-, Qc- and R-SNARE motifs. 
After fusion, the SNARE complex is transformed from a trans- to cis- configuration 
and finally disassembled by ATPase N-ethylmaleimide-sensitive factor (NSF) and 
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soluble NSF attachment proteins (SNAPs) (Sollner et al., 1993). The free SNARE 
proteins then are available for the subsequent rounds of membrane fusion. 
The essential role of SNARE proteins in exocytosis was first recognized when it was 
discovered that clostridial zinc proteases of the tetanus and botulinum neurotoxin 
family specifically cleave SNARE proteins and thus block neurotransmission (Blasi et 
al., 1993; Penner et al., 1986; Schiavo et al., 1992). The cleavage sites of SNARE 
proteins for tetanus and botulinum toxin are shown in Fig. 3. Treatment with different 
neurotoxins generates a variety of truncated SNARE proteins inducing distinct 
deficits in secretion. This has allowed study of the function of the various SNARE 
proteins (Xu et al., 1999). Genetic deletion of SNAREs blocks most but not all 
neurotransmitter release, indicating a degree of redundancy in function of these 
molecules (Scales et al., 2001; Sorensen et al., 2003). 
 
 
Figure 3. SNARE complex layers and 
neurotoxin cleavage sites. 
A. Trans-SNARE complex connecting vesicle 
(curved) and plasma membrane (straight), 
consisting of synaptobrevin-2 (blue), syntaxin 
(red) and SNAP-25 (green). Arrows indicated 
neurotoxin cleavage sites.  
B. Structural organization of the SNARE complex, 
hydrophobic layers are numbered. (Modified 
from (Sutton et al., 1998)) 
 
 
 
 
 
 
 
As the SNARE motifs of synaptobrevin and syntaxin are adjacent to their C-terminal 
transmembrane domain, formation of a bundle containing four parallel helices of the 
SNARE motifs should bring the vesicle and the plasma membrane into close 
proximity (Chen and Scheller, 2001; Rizo and Sudhof, 2002). Fully assembled 
SNARE complexes are extraordinarily stable and resistant to denaturation by heat 
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and SDS (Fasshauer et al., 1998a). It is believed that assembly of the SNARE 
complex provides the energy to overcome repulsive the electrostatic forces of 
membrane fusion. When t-SNAREs and v-SNAREs are incorporated into separate 
populations of liposomes, fusion occurs spontaneously. Reconstitution experiments 
indicate that the SNAREs alone are sufficient to promote liposomal fusion (Weber et 
al., 1998). However under these conditions, liposomal fusion is much slower, with 
time scales of hours, than the exocytosis observed in neurons. Removal of the 
N-terminal domain of syntaxin can dramatically increase the fusion rate of artificial 
bilayers, implying a negative regulatory role of the syntaxin N-terminal Habc domain 
(Parlati et al., 1999). It has been shown that the syntaxin Habc domain can fold back 
on itself and bind with syntaxin SNARE motif resulting in a so-called “closed 
conformation” that inhibits the assembly of the SNARE complex (Dulubova et al., 
1999). Syntaxin and SNAP-25 tend to form a stable four-helix bundle in 2:1 
stoichiometry in vitro, which can also hinder the SNARE complex assembly 
(Fasshauer et al., 1998b). Introduction of a short C- terminal stretch of the 
synaptobrevin SNARE motif prevents the formation of unproductive 2:1 
syntaxin-1-SNAP-25 hetetrodimers and accelerates liposome fusion (Pobbati et al., 
2006). This result supports the idea that the assembly of SNARE complex starts from 
the N-terminal and zippers up toward the C-terminal. Mutations in the N- and 
C-terminal SNARE motifs of SNAP-25 induce differential inhibition of secretion 
providing additional evidence for N- to C- terminal zippering model (Sorensen et al., 
2006). Sequential N- to C-terminal SNARE complex assembly exerts a mechanical 
force on membranes which may mediate membrane fusion. In this case, the linker 
region between the SNARE motif and the transmembrane domain appears to be 
critical as a force transducer to translate the energy released by SNARE complex 
assembly into the catalytic force for membrane fusion (Sudhof and Rothman, 2009). 
Insertion of extra amino acids between the SNARE motif and the transmembrane 
domain of synaptobrevin inhibits Ca2+ evoked exocytosis, consistent with this force 
model (Kesavan et al., 2007). 
In summary, SNARE proteins are the key elements in membrane fusion of all 
eukaryotic organisms. Investigations of how SNARE proteins act and how they 
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cooperate with other molecules will provide new insights into the molecular 
mechanism of exocytosis. 
1.3.2 Munc13 
Munc13s are mammalian homologs of unc-13, a gene identified by mutation 
screening in C. elegans, as a gene whose mutation leads to an uncoordinated (unc) 
phenotype. Munc13s are priming factors in neuron and neuroendocrine cells. They 
contain one diacylglycerol (DAG) binding and phobol-ester binding C1 domain, two 
Munc13 homologue domains (MHD) and three C2 domains (the structure shown in 
Fig. 4). The Munc13 homology domains are crucial for the priming role of Munc13 in 
synaptic transmission. 
 
 
Figure 4. Domain structure of Munc13-1 and CAPS. MHD, Munc13 homology domain. PH, 
pleckstrin homology domain. 
 
Glutamatergic hippocampal neurons from mice lacking Munc13-1 form 
ultrastructurally normal synapses whose neurotransmitter release is strongly inhibited, 
indicating that Munc13-1 is essential for synaptic transmission (Augustin et al., 1999). 
However, synaptic transmission is not completely blocked in Munc13-1 deletion 
mutants, due to the presence of Munc13-2 in these cells. Deletion of both Munc13-1 
and Munc13-2 totally abolished the spontaneous and evoked synaptic transmission 
(Varoqueaux et al., 2002). Studies from Munc13-1 knockout mutants, Munc13-2 
knockout mutants and double knockout mutants indicate that both Munc13-1 and 
Munc13-2 are priming factors and differentially control short-term plasticity in synaptic 
transmission (Rosenmund et al., 2002). Although the expression level of Munc13-1 in 
chromaffin cells is very low, overexpression of Munc13-1 in bovine chromaffin cells 
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leads to three-fold increase of Ca2+ evoked secretion but does not change the 
distribution of vesicles. Thus it is likely that Munc13-1 acts as a priming factor 
(Ashery et al., 2000). 
Biochemical studies show C-terminal structures of Munc13-1 interact with the 
N-terminus of syntaxin (Betz et al., 1997). Overexpression of an open form of 
syntaxin partially rescues neurotransmitter release in unc-13 null mutants in C. 
elegans, indicating that Munc13´s displacement of Munc18 from syntaxin facilitates 
the assembly of SNARE complex (Richmond et al., 2001). The minimal domains 
required for Munc13 function include the two Munc13 homologue domains followed 
by a C2 domain (Basu et al., 2005; Stevens et al., 2005). Point mutations deficient in 
binding with syntaxin block the priming activity of Munc13, supporting the conclusion 
that the interaction between Munc13 and syntaxin is crucial for Munc13´s function 
(Madison et al., 2005; Stevens et al., 2005). 
Munc13s also bind to other factors modulating the synaptic transmission. It has been 
found that Munc13 interacts with RIM and Rab3A to form tripartite complex mediating 
vesicle targeting to the presynaptic active zone (Dulubova et al., 2005; Schoch et al., 
2002). Mutation studies show that DAG/ß phorbol ester binding to the C1 domain of 
Munc13-1 induces augmentation of neurotransmitter release (Rhee et al., 2002). 
Munc13 and Calmodulin form Ca2+ sensor/effector complex which controls the short 
term synaptic plasticity in neuron (Junge et al., 2004).  
1.3.3 CAPS 
CAPS (Ca2+-dependent activator protein for secretion) was identified as a 145-kDa 
soluble protein which reconstitutes Ca2+-dependent secretion in permeabilized PC12 
neuroendocrine cells. A CAPS-specific antibody inhibits the reconstitution of 
Ca2+-activated secretion by cytosol containing CAPS, indicating an essential role of 
CAPS for neurotransmitter release (Walent et al., 1992). Later it was found that 
CAPS is the mammalian homologue of unc-31 in C. elegans (Ann et al., 1997). 
Unc-31 mutant worms exhibit uncoordinated movements and diverse defects in 
behaviour suggesting unc-31 is an important nervous system protein (Avery et al., 
1993). The CAPS homologue in Drosophila is also involved in neurotransmitter 
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release. Null dCAPS mutants display a reduction of glutamatergic transmission and 
locomotor deficits (Renden et al., 2001). CAPS binds to Ca2+ with low affinity (Kd = 
270 µM), indicating that CAPS function may be Ca2+-dependent.  
Mammals express two CAPS isoforms that are highly homologous to unc-31 and 
dCAPS (Speidel et al., 2003). Both isoforms contain one C2 domain proximal to the 
N-terminus, a Pleckstrin homology (PH) domain located centrally, a Munc13 
homology domain (MHD) and a C-terminal membrane-association domain (structure 
shown in Fig. 4; (Grishanin et al., 2002)). Recent studies show that there is also an 
N-terminal dynactin 1 binding domain (DBD) that may be required for protein sorting 
(Sadakata et al., 2007). The C2 domain is known to bind with Ca2+ thus likely acts as 
a Ca2+ sensor. The PH domain associates with acidic phospholipids and could 
mediate an interaction between CAPS and plasma membranes. The Munc13 
homology domain is required for priming activity of unc-13 homologs in Mouse and C. 
elegans, consistent with the results indicating that CAPS may also be a priming factor. 
The C-terminal membrane-association domain is required to mediate the binding to 
large dense core vesicles (LDCVs). Both CAPS isoforms are present in brain and 
adrenal gland but exhibit different developmental expression patterns. CAPS-1 
protein expression is first detectable late in embryo-genesis (E14) and increases to 
reach a plateau 20 days after birth. In contrast, CAPS-2 protein expression is more 
stable during development and even higher in the embryonic brain than in later 
phases of development (Speidel et al., 2005). CAPS-1 protein is also found in mouse 
pancreas, whereas CAPS-2 is present in liver, testis, lung, kidney and pancreas 
(Sadakata et al., 2006; Speidel et al., 2003). The different tissue distribution indicates 
a CAPS-1 function in neuronal and neuroendocrine tissues. Since CAPS-2 is also 
found in other tissues, it may be involved in secretion in non-neuronal cells. 
The function of CAPS in Ca2+-triggered vesicle release has been intensively 
investigated. In synaptosomes, CAPS is associated with LDCVs but not with SVs 
suggesting CAPS selectively regulates the LDCVs exocytosis (Berwin et al., 1998; 
Tandon et al., 1998). Studies from Drosophila show that the dCAPS null mutants 
reveal a reduction of neurotransmission and an accumulation of LDCVs and SVs in 
presynaptic terminals at the NMJ (Renden et al., 2001). Reintroduction of dCAPS into 
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identified motoneurons on the dCAPS null background failed to rescue glutamatergic 
synaptic transmission suggesting that dCAPS is required but not directly responsible 
for SV release. Studies from C. elegans using a prepro-atrial natriuretic factor-green 
fluorescent protein fusion protein (ANF-GFP) as an index of release of dense-core 
vesicle exocytosis also indicate that UNC-31 is specifically required for LDCVs but 
not SVs exocytosis (Speese et al., 2007). However the groups of Brose and Rhee 
have examined synaptic transmission in autaptic cultures of neurons from mouse 
hippocampus and concluded that CAPS is required for synaptic vesicle priming 
(Jockusch et al., 2007). They found that deletion of CAPS-1 and CAPS-2 results in a 
strong reduction in EPSC amplitude which is caused by a reduction of readily 
releasable pool size of vesicles. The ultrastructure of synapses, the synapse 
numbers and the distribution of LDCVs and SVs are normal in the absence of CAPS. 
High-frequency stimulation in CAPS deficient neurons caused an augmentation of 
secretion. Increasing the extracellular calcium concentration could transiently bypass 
the priming defect caused by deletion of CAPS. The results indicate that CAPS is 
directly involved in the priming of SVs. It has been reported that CAPS acts via LDCV 
exocytosis to activate the neuronal Gαs pathway, thus modulating synaptic 
transmission in motor neurons from C. elegans (Charlie et al., 2006).  
The role of CAPS in LDCV exocytosis has been studied by a number of different 
approaches. Antibody studies in bovine chromaffin cells show that catecholamine 
release induced by sequential trains of action potentials is inhibited when a CAPS 
specific antibody is applied via patch pipette, consistent with a role of CAPS in 
LDCVs secretion. The kinetic characteristics of amperometric spikes were also 
changed in these experiments indicating that CAPS is involved in the LDCVs 
exocytosis, modulating fusion pore formation and dilation (Elhamdani et al., 1999). 
Application of CAPS antibody in rat melanotroph cells showed that CAPS is required 
for the rapid secretory response but not for the slow component upon flash photolysis 
of caged Ca2+ (Rupnik et al., 2000). Knockdown of CAPS-1 in PC12 cells (CAPS-2 
was not expressed at a detectable level in these cells) resulted in a reduction of 
release of NE and of a transfected neuropeptide Y (NPY) secretion, indicating that 
CAPS is required for the priming of LDCVs (Fujita et al., 2007). CAPS-1 deficient 
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mice have been generated and investigated. New-born CAPS-1 knockout mice die 
immediately after birth. Capacitance measurements show that exocytosis is not 
affected in chromaffin cells of CAPS-1 deletion mutants. However, amperometric 
records indicate a deficit in catecholamine release in CAPS-1 knockout mice, with no 
change of event charge, amplitude, rise time, half-width or foot duration. Studies 
combined with TIRF microscopy and amperometry show that in CAPS-1 deficient 
chromaffin cells many vesicles fuse with the plasma membrane without 
catecholamine release implying the exocytosis of empty vesicles. The results indicate 
that CAPS-1 regulates the catecholamine loading of LDCVs (Speidel et al., 2005), 
which is supported by the recent reports that overexpression of either CAPS-1 or 
CAPS-2 in CHO cells enhances vesicular monoamine uptake via the vesicular 
monoamine transporters VMAT1 and VMAT2 (Brunk et al., 2009). Studies from 
primary cultured C. elegans neurons using capacitance recordings and TIRF 
microscopy indicate that CAPS is required for the docking of LDCVs at the plasma 
membrane (Zhou et al., 2007). Electron microscopy studies also support a docking 
role of CAPS in C. elegans. An open form of syntaxin can reverse the docking deficit 
in the absence of CAPS (Hammarlund et al., 2008). In summary, capacitance 
experiments indicate a role for CAPS in priming, while imaging and electron 
microscopy studies support a role for CAPS in docking. Examination of 
catecholamine release indicates an additional role for CAPS in vesicle filling. It is still 
unclear where in the secretory pathway CAPS acts. 
At which steps of LDCVs exocytosis CAPS acts is still not clear. It has been found 
that the full length of CAPS binds to acidic phospholipids, the plasma membrane and 
phosphatidyl inositol 4,5 bisphosphate (PI (4, 5) P2) through PH domain, and the 
presence of PI (4, 5) P2 and PI (3, 5) P2 enhances the binding of CAPS with the 
plasma membrane (Grishanin et al., 2002). Using a SNARE-dependent liposome 
fusion assay, it has been shown that CAPS accelerate liposome fusion in a calcium- 
and PIP2-dependent manner. CAPS with mutations in PH domain impairing the 
binding with PIP2 failed to promote the liposome fusion, thus indicating that PIP2 
binding is required for CAPS-mediated acceleration of secretion (James et al., 2008). 
Recently Nojiri et al showed that the phosphorylation of CAPS by protein kinase CK2 
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is required for CAPS activity (Nojiri et al., 2009). They identified Ser-5, -6 and -7 as 
phosphorylation sites using mass spectrometry. Nonphosphorylatable CAPS mutants 
did not support secretion in vitro and in vivo indicating phosphorylation is necessary 
for CAPS activity. The presence of an MHD domain in CAPS leads to a hypothesis 
that CAPS interacts with syntaxin, as Munc13-1 does. James et al. tested this 
hypothesis by using liposome fusion assay and suggested that CAPS binding with 
syntaxin-1 promotes the trans-SNARE complex formation to accelerate fusion 
(James et al., 2009). 
1.4 Aim of my work  
The aim of this work is to investigate the function of CAPS in Ca2+ evoked exocytosis 
in chromaffin cells. As introduced above, mammals express two CAPS isoforms 
which share a similar domain structure. A variety of studies designed to perturb 
CAPS function indicate that CAPS is involved in the secretion of large dense core 
vesicles, but where in the secretory pathway CAPS acts is still under debate. CAPS-1 
knockout mice have been generated and investigated. We have used CAPS-2 
knockout (KO) mice and CAPS-1/CAPS-2 double knockout (DKO) mice to further 
study how CAPS functions in regulated exocytosis.  
Using high time resolution recording of secretion via membrane capacitance 
measurements, combined with photolysis of Ca2+-caged compound, we have 
examined the role of CAPS-1 and CAPS-2 on a genetically clean, CAPS-free 
background. We have examined docking, priming and catecholamine release in cells 
lacking CAPS and we examined the effects of expression of CAPS-1 and CAPS-2 in 
these cells. We have tested whether CAPS can be replaced in the system. The 
results of these experiments will add to our understanding of how CAPS functions. 
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2. Materials and Methods 
2.1 Materials 
2.1.1 Reagents 
Agarose Roth 
Albumin Sigma 
Aprotinin Sigma 
BAPTA Molecular Probes 
Bovine serum albumin (BSA) Sigma 
CaCl2 (1M standard solution) BDH 
Caesium hydroxide (CsOH) Sigma 
DMEM Invitrogen 
DPTA Aldrich 
EDTA Sigma 
Ethanol Roth 
Fetal calf serum (FCS) Invitrogen 
Fura-4F Molecular Probes 
Furaptra Molecular Probes 
Glucose Merck 
ITS-X Invitrogen 
L-cysteine Sigma 
L-glutamate acid Sigma 
Normal goat serum (NGS) Invitrogen 
HEPES Sigma 
HPLC-H2O Merck 
NP- EGTA Hannover 
OptiMEM Invitrogen 
Pen / Strep Invitrogen 
Triton X-100 Serva 
Tris Roth 
Trpsin inhibitor Sigma 
Tryptosephosphat Invitrogen 
 
The reagents used in electron microscopy are from Electron Microscopy Science.  
2.1.2 Enzymes 
Chymotrypsin Sigma 
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Papain Roche 
 Worthington 
Proteinase K Qiagen 
RedTaq-Polymerase Sigma 
Trypsin Invitrogen 
2.1.3 Antibodies 
anti CAPS-1 monoclonal (from mouse) BD Biosciences 
anti CAPS-2 polyclonal (from rabbit ) MPI for experimental Med., Göttingen 
Alexa 568 nm goat anti-rabbit Molecular Probes 
Alexa 488 nm goat anti-mouse Molecular Probes 
2.1.4 Virus 
pSFV1- CAPS1-IRES-GFP 
pSFV1- CAPS2-IRES-GFP 
pSFV1- Munc13-1-GFP 
pSFV1- Syntaxin LE 165/166A-PV-IRES-GFP 
pSFV1- CAPS1-200-1289-PV-IRES-GFP  
2.1.5 Solutions 
2.1.5.1 General solutions 
HBS 
140 mM NaCl 
10 mM HEPES 
5 mM KCL 
10 mM MgCl2 × 6 H2O 
20 mM CaCl2 × 2 H2O 
pH 7.2, ~ 359 mOsm 
PBS 
140 mM NaCl 
7 mM KCl 
10 mM Na2HPO4 
1.8 mM KH2PO4 
sterile filtered  pH 7.4 
TAE 
40 mM Tris 
0.11 % (v/v) Acetic acid 
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1 mM EDTA 
pH 8.0 
TBS 10× 
100 mM Tris-HCl 
1.5 M NaCl 
pH 7.8 
2.1.5.2 Solutions for chromaffin cell preparation 
Locke´s 
154 mM NaCl 
5.6 mM KCl 
0.85 mM Na2HPO4 
2.15 mM KH2PO4 
10 mM Glucose 
pH 7.4, ~ 312 mOsm 
Papain solution 
50 ml DMEM 
10 mg L-Cysteine (activates the papain) 
0.5 ml 100 mM CaCl2 
0.5 ml 50 mM EDTA (activates the papain) 
frozen in aliquots (3ml or 2 ml aliquots, freezer) 
after thawing 20 units papain per 1 ml enzyme solution 
 bubble 20 minutes with carbogen 
 sterile filtered 
Inactivation solution 
50 ml DMEM 
5 ml FCS 
125 mg albumin 
125 mg trypsin inhibitor 
sterile filtered 
frozen in aliquots (3ml or 2 ml aliquots, freezer) 
after thawing incubate at 37°C , 9% CO2 incubator 
Medium 
40 ml DMEM 
400 µl ITS-X 
---------- Materials ---------- 
30 
160 µl Pen / Strep (1 ml aliquots, freezer) 
after thawing incubate at 37°C , 9% CO2 incubator 
 
2.1.5.3 Solutions for BHK cells and virus generation 
OptiMEM + 2.5% FCS 
100 ml Tryptose phosphate 
20 ml 1 M HEPES 
25 ml FCS 
1 ml Pen / Strep 
fill up to 1000 ml with OptiMEM 
sterile filtered, store at 4°C 
OptiMEM + 5% FCS 
15 ml Tryptose phosphate 
3 ml 1 M HEPES 
7.5 ml FCS 
150 µl Pen / Strep 
fill up to 150 ml with OptiMEM 
sterile filtered, store at 4°C 
OptiMEM without FCS + 0.2% BSA 
44 ml OptiMEM 
5 ml Tryptose phosphate 
1 ml 1 M HEPES 
50 µl Pen / Strep 
0.1 g BSA 
sterile filtered, store at 4°C 
Aprotinin 
6 mg / ml in HBS  
110 µl aliquots store at -20 °C 
Chymotypsin 
2 mg / ml in HBS  
100 µl aliquots store at -20 °C 
Virus is activated as following: 
450 µl Virus aliquot 
450 µl OptiMEM without FCS + 0.2% BSA 
---------- Materials ---------- 
31 
100 µl Chymotrypsin 
Mixed and incubated 40 minutes at room temperature 
Add 110 µl Aprotinin 
 
2.1.5.4 Solutions for Immunocytochemistry 
Fixation solution 
3.7 % (v/v) Formaldehyde 
0.1 % (v/v) Glutaraldehyde 
in PBS  
sterile filtered 
Blocking solution 
10 % (v/v) NGS 
0.25 % (v/v) Triton-x-100 
in PBS  
sterile filtered, store at 4°C 
1 × PBS 
58 mM Na2HPO4 
17 mM NaH2PO4 
83 mM NaCl 
pH 7.4 adjusted by NaOH, 322 mOsm 
Sterile filtered, store at 4°C 
Mounting Medium 
Mowiol 4-88 2.4 g 
Glycerol 6 g 
H2O 6 ml 
0.2 M Tris-buffer pH 8.5 12 ml  
 
2.1.5.5 Solutions for Electron Microscopy 
Paraformaldehyde  
15% dissolved in double distilled water at 70°C 
filtered after cooling, freshly made 
pH 7.1-7.4 
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Cacodylate buffer 
0.1 M and 0.2 M in double distilled water, freshly made 
pH 7.4 adjusted by HCl 
Fixation solution 
3 ml Glutaraldehyde (10%) 
1.66 ml Paraformaldehyde (15%) 
5 ml Cacodylate buffer (0.2 M) 
0.34 ml H2O 
pH 7.2 
Osmium 
2% in 0.1 M Cacodylate buffer, freshly made 
Uranyl acetate 
20 mg / ml in double distilled water, freshly made 
Lead citrate 
0.4 mg / ml  
pH 12.0 
Embedding resin  
Epon 5 g 
DDSA 3.3 g 
NMA 2.1 g 
BDMA 0.3 g 
 
2.1.5.6 Solutions for Electrophysiology 
2 × Buffer 
0.1906 g HEPES 80 mM 
0.3678 g L-Glutamate acid 250 mM 
300 µl CsOH (50%)  
8 ml HPLC-H2O 
pH 7.6 adjusted by CsOH, ~ 600 mOsm 
sterile filtered, 50 µl aliquots at -20°C 
BAPTA 
100 mM in HPLC-H2O 
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pH 7.2 adjusted by HCl, 304 mOsm 
sterile filtered, 500 µl aliquots at -20°C 
DPTA 
100 mM in HPLC-H2O 
pH 7.2 adjusted by KOH, 316 mOsm 
sterile filtered, 1 ml aliquots at -20°C 
NP-EGTA 
100 mM NP-EGTA stock in 100 mM HEPES, pH 7.2, 917 mOsm, 400 µl aliquots at 
-80°C 
after thawing, add 600 µl HPLC-H2O to get 40 mM NP-EGTA stock, 12.5 µl aliquots 
at  
-20°C 
Nucleotides 
0.0507 g Mg-ATP 20 mM 
0.0050 g Na2-GTP 2 mM 
0.0119 g HEPES 10 mM 
4 ml HPLC-H2O 
pH 7.2 adjusted by CsOH, 55 mOsm 
sterile filtered, 20 µl aliquots at -20°C 
CaCl2 
Serial dilution from 1 M standard CaCl2 solution with HPLC-H2O or HEPES buffer 
Fura-4F + Furaptra 
Same volume of 10 mM Fura-4F in 20 mM HEPES (HPLC-H2O) and 10 mM Furaptra 
in 20 mM HEPES (HPLC-H2O) mix together to get final concentration as 5 mM. 
Intracellular solution for amperometry 
4.9 µl 10 mM CaCl2 in 2 × Buffer mixed with 5.1 µl 10 mM EGTA to get 4.2 µM free 
calcium 
Extracellular solution for flash & ramp experiment 
145 mM NaCl 
2.4 mM KCl 
10 mM HEPES 
4 mM MgCl2 
1 mM CaCl2 
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10 mM Glucose 
pH 7.2, ~310 mOsm 
Intracellular solution for flash & ramp experiment  
12.5 µl NP-EGTA (40 mM) 
8 µl Nucleotides 
6.4 µl Fura-4F + Furaptra (5 mM) 
3.4 µl CaCl2 (100 mM) 
30.5 µl 2 × Buffer 
19.2 µl HPLC-H2O  
pH 7.2, ~300 mOsm 
 
Calibration Solutions 
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2.2 Methods 
2.2.1 Knockout mice 
Mice with a deletion of the mouse CAPS-1 protein (CAPS-1 knock-out) were generated 
by homologous recombination in embryonic stem cells as described previously 
(Speidel et al., 2005). The mouse CAPS-2 gene was deleted using same strategy 
(Jockusch et al., 2007). CAPS-1/-2 double knock-out (DKO) mice were generated by 
breeding the CAPS-1 mutation into the CAPS-2 mutant background. CAPS-1 
knock-out mice and CAPS-1/-2 double knock-out mice died shortly after birth, so their 
embryos [embryonic day 18 (E18) and E19] were prepared after cesarean section and 
cervical dislocation. Appearance of CAPS-1/-2 double knock-out mouse embryos was 
different from that of wild type (WT) mice (Fig. 1). CAPS-2 knock-out mice were viable 
and fertile. New born CAPS-2 knock-out mice [postnatal1-2 day] were used for 
experiments. They resembled wild type mice.  
 
 
Figure 1. CAPS-1/-2 double knock-out mouse embryo (left) shows different appearance as 
compared with wild type mouse (right). 
 
2.2.2 Genotyping of mice 
2.2.2.1 Preparation of mice genomic DNA 
Tails of mice were digested by 180 µl lysis-Reagent 2 and 20 µl proteinase K for 5 
hours or overnight at 1400 rpm, 55°C. After a short centrifuge step, the products were 
mixed for 45 minutes ~ 1 hour at 1400 rpm, 85°C. Purified DNA gotten from above 
processes can be used for next Polymerase chain reaction (PCR).  
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2.2.2.2 Polymerase chain reaction 
18.5 µl mastermix and 1 µl Red Taq polymerase were added into 0.5 µl purified DNA 
template then mixed by pipette. It is important to put all solutions always on ice, 
especially for Red Taq polymerase.  
2.2.2.2.1 CAPS-1 PCR protocol 
Primer #1502 TGC GGT GGG CTC TAT GGC TTC T 
Primer #1503 CTC GAG TGG CCT GAT CTT TGT CA 
Primer #1504 TAT GAG GAG TTT ATG TGC GTG GAT 
Primer Pair #1502/ Primer #1504 detects CAPS-1 KO 465 bp  
Primer Pair #1503/ Primer #1504 detects CAPS-1 WT 382 bp  
Reaction mix for 1 reaction 
1 µl dNTPs 2.5 mM 
1 µl Primer #1502 5 pM/µl 
1 µl Primer #1503 5 pM/µl 
1 µl Primer #1504 5 pM/µl 
2 µl PCR buffer 10 ×  
12.5 µl Sigma-H2O 
0.5 µl DNA sample 
1 µl Red Taq DNA Polymerase 
Number of cycles: 40 
1 = 94.0 °C for 5 minutes 
2 = 94.0 °C for 30 seconds 
3 = 60.0 °C for 30 seconds 
4 = 72.0 °C for 30 seconds 
5 = GO TO 2 repeat 39 
6 = 72.0 °C for 7 minutes 
7 = HOLD 4.0 °C  
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2.2.2.2.2 CAPS-2 PCR protocol 
Primer #5471 sensePrimer 5’ GTA CCA TAG TTC TGT GCC GTG TAA TC 3’ 
Primer #5472 antisensePrimer 5’ GGA GGC TCG CAG CTC TTC AAT G 3’ 
Primer #4174 antisensePrimer 5’ CGC ATC GCC TTC TAT CGC CTT CTT 3’ 
Primer Pair #5471/ Primer #5472 detects CAPS-2 KO 225 bp  
Primer Pair #5471/ Primer #4174 detects CAPS-2 WT 153 bp  
Reaction mix for 1 reaction 
1 µl dNTPs 2.5 mM 
2 µl Primer #5471 5 pM/µl 
1 µl Primer #5472 5 pM/µl 
1 µl Primer #4174 5 pM/µl 
2 µl PCR buffer 10 ×  
11.5 µl Sigma-H2O 
0.5 µl DNA sample 
1 µl Red Taq DNA Polymerase 
Number of cycles: 30 
1 = 94.0 °C for 3 minutes 
2 = 94.0 °C for 30 seconds 
3 = 60.0 °C for 30 seconds 
4 = 72.0 °C for 30 seconds 
5 = GO TO 2 repeat 29 
6 = 72.0 °C for 7 minutes 
7 = HOLD 4.0 °C 
2.2.2.3 Agarose gel electrophoresis for DNA separation 
After PCR, a 380 bp amplicon was generated for the CAPS-1 wild type allele, a 465 bp 
amplicon was generated for the CAPS-1 knock-out allele, and a 153 bp amplicon was 
generated for CAPS-2 wild type allele and a 225 bp amplicon for CAPS-2 knock-out 
allele. These DNA fragments with different lengths can be distinguished by agarose gel 
electrophoresis. 0.6 g agarose was added into 30 ml TAE solution then boiled using a 
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microwave. After the agarose dissolved totally and the solution cooled to 37°C, 3 µl 
ethidium bromide was added. The agarose solution was carefully mixed and poured 
into a gel tray to avoid air bubbles. The gel which was solidified at room temperature in 
20 minutes was put into the electrophoresis chamber contained 1×TAE buffer. DNA 
products generated using PCR were then added to gel pockets. λ –DNA marker was 
used as standard control. Electrophoresis was performed at 80 Volts for 1 hour. The 
results were visualized under UV- light illumination.  
 
 
Figure 2. An example of genotyping 
results.  
The first lane is the standard control from 
λ–DNA marker. The second, fourth and 
sixth lanes are the results of DNA products 
from CAPS-1 PCR; the third, fifth and 
seventh are the results of DNA products 
from CAPS-2 PCR. Thus the genotyping 
results from left to right are 
CAPS1+-/CAPS2--, CAPS1--/CAPS2-- and 
CAPS1++/CAPS2-- respectively. 
 
 
2.2.3 Mouse chromaffin cell culture 
Adult female and male CAPS-1+-/CAPS-2-- mice were paired in breeding cages for 2 
days and separated. Embryonic age was calculated from the first day of pairing. 
Pregnant female mice at stage E18 or E19 were asphyxiated by carbon dioxide then 
decapitated. Embryos were taken by caesarean section. Mice having unusual 
appearance as shown in Fig. 1 were highly likely to be DKOs, and were picked. 
Embryos were decapitated and placed on ice. Both adrenal glands were rapidly 
removed by forceps and scissors and then placed into a drop of cold Locke´s solution 
and carefully cleaned with fine forceps under microscopic control. It was important to 
remove fat, blood and other tissues connected with adrenal glands and avoid damage 
glands at the same time. Cleaned glands were put into another clean drop of Locke´s 
solution and then transferred into a 15 ml Falcon tube containing 400 µl of the enzyme 
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solution and digested for 20 ~ 21 minutes in a shaking water bath at 37°C. The enzyme 
solution was then removed, and 400 µl of inactivating solution was added and 
incubated 4 minutes in the shaking water bath at 37°C. The inactivating solution was 
replaced by 600 µl culture medium and the glands were carefully triturated with a 200 
µl pipette tip until the tissue was dissociated. 100 µl cell-suspensions were plated on 
sterilized 25 nm coverslips (No.1001/0025, Assistant, Germany) in six-well plates and 
were kept in the incubator (37°C, 9% CO2) for 30 minutes before adding 3 ml of culture 
medium to each well. The cells could be cultured for up to 4 days in the incubator. Wild 
type and CAPS-2 knock-out mouse chromaffin cells were prepared following similar 
steps. The enzyme digestion time was adjusted for the age of the mice. 
2.2.4 Morphological Methods  
2.2.4.1 Immunocytochemistry 
Mouse chromaffin cells were cultured for 2 days before immunostaining. The culture 
medium was removed and the cells were washed twice with 2ml PBS. Next cells were 
fixed with 3.7% Formaldehyde and 0.1% Glutaraldehyde in PBS for 20 minutes in 
darkness. Fixation solutions were prepared fresh, filtered and kept cold (4°C). During 
fixation process, shaking of the tissue was avoided. 
After washing 3 times with PBS, cells were blocked 30 minutes with blocking solution 
under gentle shaking. During this time primary antibodies were diluted in blocking 
solution and kept on ice. 100 µl diluted primary antibody solution were added per 
coverslip on a piece of parafilm. Coverslips with the cell on the underside were 
carefully put onto these drops of solution and incubated in a wet chamber (self-made) 
overnight at 4°C or 1 hour at room temperature. Then cells were washed with PBS 
twice and incubated with the second antibody diluted in blocking solution 45-60 
minutes in the dark at the room temperature under gentle shaking. After washing 3 
times with PBS, the coverslips were mounted upside down on microscope slides with 
30 µl mounting medium per coverslip and incubated for 30 minutes at 37°C. One 
coverslip without cells was used as control for the drying process of the mounting 
medium. Finally the edges of coverslips were sealed with nail polish to avoid further 
drying. All washing steps were done quickly to avoid contact of cells with air and were 
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done carefully to avoid washing cells away. CAPS-1 monoclonal antibody (from 
mouse, 1:100 v/v, BD Biosciences), CAPS-2 polyclonal antibody (from rabbit, 1:100 
v/v, N. Brose MPI for Experimental Medicine, Göttingen), secondary antibody Alexa 
488 nm goat anti-mouse (1:2000 v/v, molecular probes) and Alexa 568 nm goat 
anti-rabbit (1:2000 v/v, molecular probes) were used. 
2.2.4.2 Electron Microscopy 
Acutely dissociated chromaffin cells from wild type and CAPS-1/-2 double knock-out 
mice were plated on Petriperm dishes (Sigma-Aldrich). The cells were cultured 2 days 
before embedding. The solutions for cell embedding were freshly prepared. 
Paraformaldehyde was dissolved at 70°C, and was filtered after cooling. Cacodylate 
buffers with two different concentrations, 0.1M and 0.2 M, were made and the pH was 
adjusted to 7.4 using HCL. The fixation solution was prepared by mixing 15% 
paraformaldehyde, 10% glutaraldehyde (cat # 16120, Electron Microscopy Sciences), 
0.2 M cacodylate buffer and double distilled water to get a final concentration as 2.5% 
paraformaldehyde, 3% glutaraldehyde and 0.1M cacodylate. The cells were washed 
twice with TBS. Then they were fixed for 1 hour at room temperature using the fixation 
solution described above, under gentle shaking. After washing 3 times with 0.1 M 
Cacodylate buffer, the cells were treated with 2% Osmium in 0.1 M cacodylate buffer 
for 1 hour under gentle shaking. 2% uranyl acetate solution and embedding resin 
(Embed-512, Electron Microscopy Sciences) were prepared during this step. Uranyl 
acetate was light-sensitive and toxic. It was weighed in a Falcon tube and dissolved by 
double distilled water. Embedding resin was prepared by mixing 4 solutions of 
EMBed-812 Embedding Kit (cat # 14120, Electron Microscopy Sciences). After 
osmication, cells were washed twice for 5 minutes, with double distilled water under 
gentle shaking; 2% uranyl acetate was added and gently shaken for 1 hour in 
darkness; washed twice by double distilled water again. Serial dehydration in ethanol 
and infiltration with embedding resin were carried out as follows: 
 1. 30% ethanol, 10 minutes, gentle shaking 
 2. 50% ethanol, 10 minutes, gentle shaking 
 3. 70% ethanol, 15 minutes, gentle shaking 
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 4. 80% ethanol, 15 minutes, gentle shaking 
 5. 90% ethanol, 15 minutes, gentle shaking 
 6. 96% ethanol, 15 minutes, gentle shaking 
 7. 99% ethanol, 15 minutes, gentle shaking 
 8. Aceton, 15 minutes, gentle shaking 
 9. Aceton: Embedding resin (3:1), 30 minutes, gentle shaking 
 10. Aceton: Embedding resin (1:1), 30 minutes, gentle shaking 
 11. Aceton: Embedding resin (1:3), 30 minutes, gentle shaking 
Finally, embedding resin was added and polymerized for 48 hours at 60°C. Extra 
embedding resin was poured into embedding capsules and polymerized.  
Embedded cells were observed under the microscope. The regions having many cells 
were marked and cut out. The sample side of embedding resin was glued to 
embedding capsules. The other side with cells was trimmed into trapezoidal shape and 
sliced by diamond knife (Elementsix, Holland). Ultrathin sections (70 nm) were 
collected on single-slot, pioloform-coated grids; poststained with 2% uranyl acetate for 
10 minutes and lead citrate for 5 minutes; analyzed with a Philips Tecnai12 Biotwin 
electron microscope. Cells with large nuclei and a clear plasma membrane were 
chosen. The number and spatial distribution of vesicles were analyzed using a 
self-written labview program (National Instruments, München, Germany). An outline of 
both the plasma membrane and the nucleus was generated manually. Each vesicle 
was marked, and the shortest distance of its centre to the plasma membrane was 
determined. 
2.2.5 Electrophysiology 
2.2.5.1 Whole-cell capacitance measurement 
The patch clamp technique provides the possibility to investigate electrical properties 
of single cells. Originally it was designed to measure the current in a small patch of cell 
membrane. Since then many applications have been developed including the 
measurement of membrane capacitance with high resolution. Capacitance of cell 
membrane is proportional to the cell plasma membrane area as near 1µF/ Cm2 (Cole, 
1968). Under the whole-cell mode, an electrical connection was established between 
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the pipette and the entire cell surface, which allows recording of cell membrane 
capacitance (Fig. 3). Upon exocytosis or endocytosis, fusion or retrieval of vesicles will 
increase or decrease the cell surface area which can be evaluated by measuring 
membrane capacitance change. 
 
 
Figure 3. Whole-cell patch clamp configuration. 
Cm is the cell capacitance; Rm is the cell resistance which is 
determined by ion channels and pores in the membrane; Ra is 
the access resistance; Er is the resting membrane potential 
which is clamped to -70 mV normally. (Modified from Gillis, 
1995) 
 
 
 
In my experiments, conventional whole-cell recordings were performed with 4-6 MΩ 
pipettes (GB150F-8P, Science products, Germany) using an EPC-9 patch-clamp 
amplifier controlled with Pulse software (HEKA). Pipettes were coated with wax and 
polished. Capacitance measurements were performed using the Lindau-Neher 
technique implemented as the “sine+dc” mode of the “software lock-in” extension of 
Pulse software. A 1 kHz, 70 mV peak-to-peak sinusoid stimuli was applied at a DC 
holding potential of -70 mV. All experiments were performed at room temperature. 
Only cells with a whole cell capacitance between 4-10 pF, a series resistance lower 
than 20 MΩ and leak current less than 50 pA were analyzed. Data analyses were done 
using IGOR Pro (Wavemetrics). 
2.2.5.2 Photolysis of caged calcium and [Ca2+]i measurement 
Calcium is an important second messenger in neurosecretory cells. Intracellular 
calcium not only acts on vesicle exocytosis triggering but also regulates the earlier 
steps of secretory pathway before vesicle fusion (Voets et al., 2001). Photolysis of 
caged calcium combined with dual-wavelength ratiometric of [Ca2+]i fluorimetry allows 
accurate measurement and control of the intracellular calcium concentration spatially 
and temporally. 
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2.2.5.2.1 Purity trituration of NP-EGTA 
We used the NP-EGTA as a calcium caging compound which was developed by 
Ellis-Davies and Kaplan. It exhibits a high selectivity for Ca2+. Upon UV-illumination, its 
Kd increases from 80 nM to 1mM. Because of its low affinity for Mg2+, photolysis of 
caged NP-EGTA does not perturb the physiological Mg2+ level. Its structure is shown in 
Fig. 4. 
 
 
Figure 4. NP-EGTA complexed Ca2+. 
Upon illumination, this complex is 
cleaved to yield free Ca2+ and two 
iminodiacetic acid photoproducts 
(Invitrogen, molecular probes). 
 
 
Purity of NP-EGTA is determined by titrating with Ca2+ in the presence of the 
photosensitive calcium dye furaptra. 100 µl NP-EGTA (10 mM) in 80 mM HEPES and 
250 mM Cs-glutamate buffer was adjusted to pH 7.6 using CsOH and put into a cuvette. 
The fluorescence intensity of the testing solution excited at 350 nm (F350) and 380 nm 
(F380) was measured and used as the background. Then 1 µl Furaptra (10 mM, in 20 
mM HEPES pH=7.2) was added into the cuvette and mixed. The fluorescence ratio (R) 
was calculated as following equation: R = (F350 – F350 background) / (F380 – F380 background). 
Next a defined amount of the calcium solution (10 mM in 100 mM HEPES, serially 
diluted from 1 M standard calcium solution) was added and mixed, and the 
fluorescence ratio was recorded. This step was repeated and more calcium solution 
was added. Because the Kd of furaptra (40 µM) is much larger than the Kd of NP-EGTA 
(80 nM), Ca2+ will bind with NP-EGTA first. Only when NP-EGTA in the cuvette is 
saturated, Ca2+ will bind with furaptra and cause a change of the fluorescence ratio 
from low to high levels. As shown in Fig. 5, when 77.5 µl calcium solutions were added, 
the ratio did not change. After addition of 2.5 µl calcium solution more, the ratio 
increased obviously. The calculated purity of NP-EGTA used in this study was 80%. 
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Figure 5. Purity trituration of NP-EGTA. 
 
The purities of other calcium chelators used in this study, BAPTA and DPTA, were also 
calibrated. BAPTA with a Kd of 220 nM, can be triturated in a similar way as NP-EGTA. 
The purity of BAPTA used in this work was determined as 80%. The Kd of DPTA is 80 
µM which is in the same range of the Kd of Furaptra; Furaptra will bind with Ca2+ more 
efficiently than DPTA. The purity of DPTA was determined as 98% as experienced 
value. Since both Kd of NP-EGTA and DPTA are pH sensitive, strict control of pH is 
important. 
 
2.2.5.2.2 In vivo Calibration curve  
Fura-2 calcium indicator, was used to measure the intracellular calcium concentration. 
This method is based on the principle that Fura-2 binding with Ca2+ displays an 
absorption shift when excitation light wavelength range from 300 nm to 400 nm. As 
shown in Fig. 6, the fluorescence intensity of Fura-2 increase with the increasing Ca2+ 
concentration at excitation light wavelength 350 nm, no change at 360 nm, decrease at 
380 nm. 
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Figure 6. Spectral response of Fura-2 in 0-39 µM Ca2+ solution. (from Molecular Probes 
handbook) 
 
The ratio of fluorescence intensity at excitation light wavelength 350 nm and 380 nm 
can be used to calculate the Ca2+ concentration by the following equation: 
 [Ca2+]i = Keff *(R – Rmin) / (Rmax – R) 
 R = F350/F380 
 Rmin fluorescence ratio of free Ca2+ solution 
 Rmax fluorescence ratio of high Ca2+ concentration (10 mM) solution 
 Keff effective binding constant 
With the Kd of 220 nM, Fura-2 is a good candidate to measure calcium concentrations 
below 1µM. However the range of Ca2+ concentration in this study was from hundreds 
of nM to tens of µM. To get adequate resolution of higher Ca2+ concentrations, a 
combination of Fura-4F (Kd = 770 nM) and Furaptra (Kd = 40 µM) was used. In this 
case, an in vivo calibration curve was needed for the calculation of Ca2+ concentrations. 
Cells were patched in the whole cell configuration with different solutions of known 
Ca2+ concentration, buffered by BAPTA or DPTA. The mixture of two dyes was allowed 
to diffuse into cells and after the ratio become stable, it was recorded and the ratios 
were plotted vs Ca2+ concentration as shown in Fig. 7. 
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Figure 7. In vivo calibration curve. 
Every point is the average of several experiments.  
 
The relationship between fluorescence ratio and Ca2+ concentration can be described 
as the following equation: 
 R = Rmin – R1* [Ca2+]i /([Ca2+]i + KFura-4f) – R2* [Ca2+]i /([Ca2+]i + KFuraptra) 
 R = F350/F380 
 Rmin fluorescence ratio of free Ca2+ solution 
 Rmin– R1–R2 fluorescence ratio of high Ca2+ concentration (7.6 mM) solution 
Using this equation to fit the data points gotten from above experiments, a calibration 
curve was created to convert the fluorescence ratio to Ca2+ concentration. 
2.2.5.2.3 Photolysis efficiency at the setup  
To reach appropriate Ca2+ concentrations after the UV flash, the photolysis efficiency 
of the flash lamp was determined. A solution containing 0.5 mM NP-EGTA, 0.56 mM 
CaCl2, 0.5 mM Fura-2 was perfused into cells in the whole cell configuration and the 
fluorescence ratio was measured before and after UV flash. The recorded 
fluorescence ratio was converted to Ca2+ concentration based on the Fura-2 
calibration curve. The basal Ca2+ concentration of the calibration solution was 
calculated to be 175 nM. Post-flash Ca2+ concentrations are variable depending on 
different photolysis efficiencies. Ca2+ concentrations measured experimentally and 
those calculated with the program should be in agreement. The flash lamp photolysis 
efficiency was adjusted to near 30% by using a neutral density filter if it is too high, and 
increasing the flash strength if it is too low. 
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In the whole-cell patch clamp mode, caged-calcium compound (NP-EGTA) and 
calcium indicators (Fura-4F and Furaptra) were perfused into the cell. Upon 
UV-illumination (Rapp Opto Electronics, Hamburg, Germany), calcium was cleaved 
from NP-EGTA compound and released, producing a step-like increase of intracellular 
calcium concentration. The mixture of two fluorescence dyes was excited with 
UV-illumination alternated between 350 nm and 380 nm with the monochromator 
(Polychrome, TILL Photonics, Planegg, Germany), emission was monitored at 510 nm. 
2.2.6 Amperometry 
Amperometry provides an additional method to investigate exocytosis. A small-sized 
carbon fibre electrode was fabricated to detect the transmitter release from single cells. 
The carbon fibre electrode is held at a constant electrical potential greater than the 
redox potential of the catecholamine we want to measure and positioned very close to 
the cell to minimize the transmitter diffusion effect. When the released transmitters 
contact the surface of the carbon fibre, they are oxidized immediately generating an 
electrical signal which is recorded as current at the carbon fibre surface. 
2.2.6.1 Fabrication of carbon fibre electrodes 
Carbon fibre electrodes used for amperometry were produced as following. Copper 
cannulas were cleaned; the carbon fibres (5 µm diameter) were glued to the copper 
cannulas using a conducting carbon paste (Electrodag 5513, Bavaria Elektronik, 
Germany). When the glue was dry, the copper cannula with a carbon fibre was glued 
inside a glass pipette using a drop of 2-component epoxy glue. After hardening 
overnight, the pipettes were then pulled with a conventional puller. The carbon fibre 
extending beyond the pulled pipette tip was put into a drop of cathodal paint 
(Electrocoating ZQ 84-3255, BASF, Germany) on a U-shaped platinum foil and coated 
by electrolysis. The assembly was then baked for 4 min at 190°C. The junction 
between the fibre and the glass was sealed with Sylgard and baked again for 4 min at 
190°C (Fig. 8). Before use, the carbon fibres were cut to expose the tip for recording 
and tested on stimulated chromaffin cells. The electrode was connected to the head 
stage of an EPC7 patch-clamp amplifier (HEKA), and a holding potential of -800 mV 
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was applied in the voltage-clamp mode. When the carbon fibre was immersed into the 
extracellular solution, the appearance of a large spike of current indicates the electrode 
sensitivity. The carbon fibre then was positioned lightly touching the surface of a 
chromaffin cell. The chromaffin cell was mechanically stimulated by a glass pipette. 
Released catecholamines from chromaffin cell contacting with the carbon fibre were 
immediately oxidized, producing a spike-like current indicating catecholamine 
sensitivity. 
 
 
Figure 8. Schematic steps of carbon fiber 
electrodes fabrication. 
A. The carbon fibre is glued to the copper wire.  
B. The copper wire with a carbon fibre is glued to 
a glass pipette.  
C. The pipette is pulled by a puller. The carbon 
fibre extending beyond the pulled pipette tip is 
trimmed to around 2 mm.  
D. The trimmed carbon fibre tip is coated with 
EDP. (Modified from (Bruns, 2004)). 
 
 
 
 
 
 
 
 
2.2.6.2 Single spike analysis 
The highly sensitive amperometric method allows detection of single vesicles 
exocytosis. As shown in Fig. 9, a spike represents the secretion from an individual 
vesicle. Analysis of single spike characteristics of amplitude, charge, half-width, 50% 
to 90% rise time provides information about the vesicle fusion event. Vesicle release 
probability can also be examined by measuring the frequency of spikes. Sometimes 
the spike is preceded with a small “foot” like signal which reflects the diffusion of 
transmitters through an opening fusion pore. Kinetic analysis of this foot signal was 
used to investigate the formation and dilating of fusion pore. 
---------- Methods ---------- 
49 
 
 
Figure 9. Example of amperometric spikes.  
Inset is the enlarged single spike with preceded foot. 
Below the single spike is the schematic graph of dilating 
of fusion pore. (Modified from (Borisovska et al., 2005)) 
 
 
 
 
 
 
 
 
 
To get separate individual spikes, the stimulation to trigger exocytosis should be 
moderate. In this study an intracellular solution containing 4 µM free calcium was 
perfused into the cell. Before the formation of whole-cell configuration, the carbon fibre 
electrode was placed lightly on the patched cell. After sealing and subsequently break 
in, the calcium solution diffused into cells causing secretion, which was monitored by 
the carbon fibre electrode. The amperometric signals were filtered at 3 kHz. Spikes 
with amplitude larger than the averaged noise level were collected. Pre-spike foot 
(PSF) signals were determined and analyzed as previously described (Mosharov and 
Sulzer, 2005). 
2.2.6.3 Combined amperometry and capacitance measurement 
Capacitance measurements indicate the change of cell plasma membrane surface 
area. Fusion of vesicles with the plasma membrane increases the plasma membrane 
area. Retrieval of vesicles decreases the plasma membrane area. Both exocytosis and 
endocytosis can be detected by capacitance measurement. Amperometry directly 
detects the released transmitter thereby avoiding errors caused by endocytosis. 
However amperometric measurement is affected by the diffusion of the transmitter 
from cell to carbon fibre and not all vesicles are released adjacent to the carbon fibre. 
Thus there are variabilities in the response. Combined amperometry and capacitance 
measurement provide two independent and complementary methods to investigate 
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exocytosis. 
 
 
Figure 10. Combined amperometry and capacitance 
measurement. 
The flux of Ca2+ through Ca2+  channel trigger 
exocytosis detected by amperometry and capacitance 
measurement simultaneously. 
 
 
 
 
 
2.2.7 Data analysis 
Data obtained were analyzed with IGOR Pro (Wavemetrics, Lake Oswego, OR). 
Capacitance curves of flash experiments were fit with the following equation: f(t) = A0 + 
AF*(1 - exp(-(t-T0)/TF)) + AS*(1 - exp(-(t-T0)/TS)) + SL*(t-T0). A0 is the cell capacitance 
before flash. T0 is the fitting starting time point. AF, AS, TF, TS are the amplitude and 
time constant of RRP and SRP respectively. SL represents the sustained release rate 
(fF/s). Capacitance curves of ramp experiments were fit with the following equation: 
f(x) = Base+Max_1/ (1+exp ((xhalf_1-x)/rate_1)) +Max_2/ (1+exp ((xhalf_2-x)/rate_2)). 
Base is the cell capacitance before ramp. Max_1, Max_2, xhalf_1, xhalf_2, rate_1, 
rate_2 are maximum amplitude, x value of half maximum amplitude and rate of first 
and second component respectively. Data are shown as Mean ± SEM. 
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3 Results 
3.1 Secretion from CAPS-2 deficient mice  
3.1.1 Deletion of CAPS-2 does not change the secretion 
We have examined the release of catecholamines from CAPS-2 KO mice. In contrast 
to CAPS-1 KO mice, CAPS-2 KO mice did not show a perinatal lethal phenotype. To 
make the results comparable with the data from CAPS-1 KO cells published 
previously, chromaffin cells from new born (p1) CAPS-2 KO and wild-type mice were 
used. The caged calcium compound and fluorescence dye are loaded into cells 
through the glass pipettes in the whole-cell mode. Upon a UV flash, the intracellular 
calcium concentration is elevated triggering secretion which is detected as a 
capacitance change and amperometric responses simultaneously. By combining 
flash photolysis, which allows immediate, global increases in calcium, with ratiometric 
calcium monitoring, we bypassed problems of microdomains while confirming that 
intracellular calcium levels in controls and CAPS-2 KO mice were comparable. The 
results are shown in Fig. 1. The pre-flash [Ca2+]i (337.8 ± 18.6 nM in CAPS-2 KO; 
350.3 ± 17.6 nM in WT) and post-flash [Ca2+]i (22.2 ± 2.0 µM in CAPS-2 KO; 24.2 ± 
2.5 µM in WT) are comparable in CAPS-2 KO and wild-type cells. Both capacitance 
measurement and integration of amperometric response indicate that the secretion 
from CAPS-2 KO chromaffin cells was unchanged compared to wild-type cells. The 
capacitance increase was fitted as the sum of two exponentials and a linear phase 
estimating the size of two releasable pools and the sustained release rate. The 
amplitude of RRP (88.5 ± 9.2 fF in CAPS-2 KO; 99.5 ± 17.5 fF in WT) and SRP (95.8 
± 19.6 fF in CAPS-2 KO; 123.9 ± 19.6 fF in WT) as well as the sustained release rate 
(17.4 ± 2.0 fF/s in CAPS-2 KO; 19.8 ± 3.1 fF/s in WT) were not significantly different 
between the CAPS-2 KO and wild-type cells. The time constants of RRP (28.8 ± 4.0 
ms in CAPS-2 KO; 30.1 ± 4.7 ms in WT) and SRP (590.4 ± 125.3 ms in CAPS-2 KO; 
612.7 ± 186.7 ms in WT) were also not different. 
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Figure 1. Secretion of chromaffin cells from CAPS-2 
deficient mice is not altered.   
A. Averaged calcium concentration ([Ca2+]i; top), 
capacitance (∆Cm; middle) and cumulative 
amperometric charge (Qamp; bottom) in response to 
flash-photolysis of NP-EGTA in wild-type cells (black; 
n=21, N=2) and CAPS-2 KO cells (red; n=23, N=2). 
Both capacitance and amperometric traces of CAPS-2 
KO cells show a similar secretion as WT cells.  
B. Kinetic analysis of experiment shown in (A). The 
amplitude of RRP and SRP as well as the rate of 
sustained component are not significantly different 
between the two groups (mean ± SEM). 
 
 
 
 
 
 
 
 
 
3.1.2 The calcium-sensing is not changed when CAPS-2 is absent  
To test whether the absence of CAPS-2 causes a change of the calcium-sensing, 
ramp experiments are performed with CAPS-2 KO and wild-type cells. In contrast to 
the stepwise increase of [Ca2+]i in flash experiments, a slowly increasing calcium 
concentration in a ramp-like manner is generated by a sequence of UV illuminations. 
The secretion is measured as the change of capacitance. The results are shown in 
Fig. 2. In CAPS-2 KO and wild-type cells the [Ca2+]i is continuously elevated from 
several hundreds of nM to tens of micromolar in a similar pattern. The [Ca2+]i in 
CAPS-2 KO cells is comparable with that of wild-type cells and the capacitance 
response in CAPS-2 KO cells is quite similar to that of wild-type cells, the 
calcium-sensitivities appear to be unchanged in CAPS-2 KO chromaffin cells. The 
averaged total secretion in CAPS-2 KO cells is 246.4 ± 45.1 fF which is also 
comparable to the secretion of wild-type cells (267.0 ± 50.2 fF), consistent with the 
oberservations in flash experiments.  
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Figure 2. Calcium-sensing is not altered in 
CAPS-2 KO mouse chromaffin cells. 
A. The calcium concentration ([Ca2+]i) is raised 
slowly and continuously by alternative weak UV 
illumination of 350 and 380 nm. There is no 
significant difference of calcium concentration 
between CAPS-2 KO (red; n=23, N=2) and 
wild-type (black; n=21, N=2) cells (mean ± 
SEM). B. The capacitance trace (∆Cm) from 
CAPS-2 KO cells is similar as WT cells. 
 
 
 
 
 
3.1.3 CAPS-2 deficiency has no effect on vesicle fusion 
Next amperometric measurements were performed to quantify the single vesicle 
secretory events. Wild-type and CAPS-2 KO Cells were perfused by 4 µM calcium 
solution through glass pipettes to stimulate the secretion. A carbon fibre electrode 
was placed close to the cell detecting the released catecholamines. In Fig. 3A, 
representative amperometric traces from wild-type and CAPS-2 KO cells are shown. 
Every single spike represents the fusion of a single secretory granule. The kinetic 
parameters of single spikes are shown in Fig. 3B-G. There was no difference in 
amplitude, charge, 50%-90% rise time, half-width and foot-duration between the WT 
and CAPS-2 KO cells (Fig. 3B-F). The event frequency of CAPS-2 KO cells (1.6 ± 0.2 
events/s) was also comparable with that of wild-type cells (1.8 ± 0.2 events/s) which 
is consistent with the observation from flash and ramp experiments. 
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Figure 3.  The characteristics of fusion 
are unchanged in CAPS-2 KO mouse 
chromaffin cells.  
A. Representative amperometric trace from 
wild-type (upper) and CAPS-2 KO (lower) 
chromaffin cells perfused by 4 µM calcium 
solution.  
B–G. Average of cell medians of 
amperometric event parameters. Amplitude 
(B), half-width (C), 50%-90% rise time (D), 
charge (E), foot duration (F) and event 
frequency (G) are statistically identical 
between two groups (mean ± SEM). Data are 
collected from 1533 events of 16 wild-type 
cells and 1304 events of 14 CAPS-2 KO cells.  
 
 
 
 
 
 
 
 
 
 
 
 
3.2 Secretion from CAPS-1/CAPS-2 DKO mice 
3.2.1 CAPS DKO cells exhibit a large deficit in exocytosis 
We then compared secretion in CAPS DKO mice with that observed in wild-type cells. 
After flash photolysis, the intracellular free calcium was raised instantly from the 
resting level of ~450 nM to ~20 µM. This increase in calcium caused fusion of 
catecholamine-containing vesicles, leading to an increase in cell capacitance (Fig. 4A, 
∆Cm). The cumulative charge (Qamp) measured by the carbon fiber is shown in the 
third trace. Secretion as measured either by capacitance change or amperometric 
charge was less in the CAPS DKO cells than that observed in the wild-type cells (46 
and 38% of WT values, respectively). The relatively larger reduction in amperometric 
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current can be attributed to the influence of CAPS on vesicle filling (presence of 
empty vesicles) as reported previously (Speidel et al., 2005).  
Exocytosis of LDCVs in chromaffin cells is a highly regulated event consisting of a 
burst phase and a sustained phase. The burst phase consists of release of an RRP 
and a slowly releasing pool (SRP) of vesicles. The sustained release phase is 
attributable to maturation (priming) of LDCVs that were not primed at the time of the 
initial calcium increase, followed by their fusion (Burgoyne and Morgan, 2003; Rettig 
and Neher, 2002; Sorensen, 2004). The responses were fit as the sum of two 
exponentials, one each for the RRP and SRP, and a linear component of sustained 
release. Summarized results are shown in Fig. 4B. The burst phase of vesicle fusion 
in wild-type chromaffin cells was measured as a capacitance change of 153.4 fF, with 
65.4 ± 8.3 fF contributed by the RRP and 88 ± 17.3 fF contributed by the SRP. The 
sustained release in the wild-type cells was 19.5 ± 2.2 fF/s. In CAPS DKO chromaffin 
cells, the burst phase of fusion amounted to 101.8 fF, with 31.3 ± 9.8 fF attributable to 
the RRP and 70.5 ± 14.5 fF attributable to the SRP. The reduction in the RRP in 
CAPS DKO cells was highly significant, whereas the reduction in the SRP was not, 
possibly indicating a selective action of CAPS on the RRP. Sustained secretion was 
virtually absent (0.5 ± 2.1 fF/s) in the DKO cells. The release time constants for the 
RRPs (29 ± 9 vs 56 ± 15 ms) and SRPs (400 ± 56 vs 500 ± 51 ms), in wild-type and 
CAPS DKO chromaffin cells, respectively, were not significantly different ( p > 0.05).  
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Figure 4. Catecholamine secretion is 
suppressed in CAPS DKO chromaffin cells 
compared with wild-type cells.  
A. The intracellular calcium after flash 
photolysis of NP-EGTA (top trace) is shown 
along with capacitance changes (∆ Cm) and 
cumulative charge (Qamp) released from 
chromaffin cells as determined by 
amperometric measurements using carbon 
fiber electrodes in wild-type (WT; black traces; 
n=30) and CAPS DKO (red traces; n=29) 
chromaffin cells. Both the capacitance 
response and the amperometric response 
indicate a strong reduction in secretion in the 
CAPS DKO cells.  
B. Kinetic analysis of the capacitance 
responses indicates that the CAPS DKO cells 
exhibit a significantly reduced RRP and a 
strong reduction in the sustained component 
(Sust. Rate; ***p<0.001). The SRP was not 
significantly reduced, although the average 
SRP was also smaller. Error bars indicate 
SEM. 
 
3.2.2 CAPS deficiency does not change morphological docking 
The reductions in the burst amplitude and in the sustained component of release 
observed in CAPS DKO chromaffin cells are consistent with a deficit in available 
vesicles at the plasma membrane or a defect in vesicle priming. To distinguish 
between these two alternatives, we quantified LDCVs in chromaffin cells using 
electron microscopy. We examined the density and location of LDCVs (wild type, 
3281 from 28 cells; DKO, 4090 from 28 cells) with respect to the plasma membrane. 
Wild-type cells and CAPS DKO cells exhibited a similar distribution of vesicles (Fig. 
5). The mean numbers of “morphologically docked” vesicles, those with centres 
within a vesicle radius (~80 nm) of the plasma membrane, were not different in the 
two populations. Thus, the observed reduction in secretion is most likely attributable 
to a defect in priming rather than in docking of LDCVs. 
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Figure 5. The distribution of LDCVs in CAPS DKO chromaffin cells is similar to that 
observed in wild-type chromaffin cells.  
A. and B. Electron micrographs showing wild-type (A) and CAPS DKO (B) chromaffin cells. Scale 
bars, 2 µm. C. Higher-magnification micrographs showing details of individual vesicles in 
chromaffin cells. Scale bars, 200 nm. D. The cumulative distribution of distance of the midpoint of 
the vesicle from the plasma membrane. Although the wild-type (solid line) and DKO (dashed line) 
distributions were significantly different with p < 0.05 (Kolmogorov–Smirnov test), the greatest 
difference was 3.3% and occurred at a distance of 177 nm, outside of the morphologically docked 
zone (radius, 100 nm; gray). There was no significant difference in the density of vesicles with 
centres within a vesicle radius (80 nm) of the plasma membrane. WT, Wild type. 
 
3.2.3 Refilling of the RRP is reduced in CAPS DKO chromaffin cells 
A defect in priming efficacy would be expected to decrease not only the size of the 
releasable vesicle pools and sustained release, but also to reduce the degree or rate 
of pool recovery after stimulation. We examined the recovery of the releasable 
vesicle pools using paired flash stimulations (Fig. 6). In these experiments, we did not 
maintain calcium at high levels after the flash, but rather allowed free calcium levels 
to decrease after the flash to allow more rapid recovery of releasable vesicle pools. 
An interstimulus interval (ISI) of 2 min between flashes allows for the recovery of 
releasable vesicle pools, and the second of a pair of responses is typically quite 
similar to the first.  
We first examined an ISI of 45 s (Fig. 6A). In wild-type cells, the burst amplitude after 
the second flash was similar to that in the first flash (Fig. 6A, left) with an RRP and 
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SRP of similar amplitude (Fig. 6A, middle). In CAPS DKO cells, the RRP was 
reduced and the SRP was moderately increased after the second flash, with a net 
decrease in the burst phase of release. With an ISI of 25 s (Fig. 6B), the secretion 
from wild-type cells was similar to that observed at a 45 s ISI, whereas the CAPS 
DKO cells exhibited a marked reduction in the RRP and an overfilling of the SRP (Fig. 
6B, middle), resulting in a net increase in the burst phase of release (Fig. 6B, right). 
With an ISI of 15 s (Fig. 6C), the wild-type cells exhibited burst responses with 
reduced RRP and increased SRP amplitudes in the second response, whereas the 
CAPS DKO cells had virtually no RRP and a more strongly enhanced SRP (Fig. 6C, 
middle), resulting in an even larger burst (Fig. 6C, right). There was no evidence of a 
sustained component in the CAPS DKO cells, with some endocytosis occurring 
during the second response. Notably, the burst amplitudes (Fig. 6C, right) of the 
wild-type responses remained constant, whereas the burst in the second flash in 
DKO mice increased at shorter ISIs. Thus, although the RRP refilled quite slowly in 
DKO mice, relative to that in the wild-type cells (Fig. 6C, middle), priming into the 
SRP approached wild-type levels at the 15 s ISI (Fig. 6C, middle). This may indicate 
that the SRP primes quickly but decays again at longer ISIs. There were no changes 
in the release kinetics of the RRP and SRP ( p > 0.2).  
The enlarged SRP at short intervals could be attributable to the increased 
intracellular calcium levels present between the two flashes. This is reminiscent of 
the temporary reversal of the deficit in transmitter release in hippocampal neurons in 
CAPS DKO mice when extracellular calcium was raised (Jockusch et al., 2007). 
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Figure 6. Responses to flash stimulation with decreasing ISIs.  
A. At an ISI of 45 s, the burst phase is fully recovered in both wild-type (n=13) and DKO (n=14) 
cells. B. When the ISI was shortened to 25 s, the RRP was reduced although the SRP was 
enhanced in wild-type (n=25) and in DKO (n=25) cells, but this trend was much stronger in the 
CAPS DKO cells. C. At an ISI of 15 s, the trend to smaller RRP and greater SRP was again 
apparent in both wild-type (n=20) and DKO (n=22) cells. The RRP in the CAPS DKO mice was 
almost nonexistent. The SRP was, in contrast, overfilled. There was no sustained component in 
the DKO cells, although one was present in the wild-type cells. The averages of pool sizes (mean 
± SEM) for the double-flash experiments are shown in the middle traces. Wild-type (black, first 
flash; blue, second flash) and DKO (red, first flash; green, second flash) cells RRPs, SRPs, and 
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sustained release rates (Sust. Rate) are shown for the 45 s interval (A), for the 25 s interval (B), 
and for the 15 s interval (C). The DKO cells exhibited less secretion in all phases of the response. 
In addition to significantly lower secretion in the DKO cells, the sustained release was strongly 
reduced. At 45 s, ISI secretion was similar to that observed at a 2 min ISI. At shorter ISIs, refilling 
of the RRP was strongly reduced in the CAPS DKO cells, whereas the SRP was refilled. The 
averaged burst responses (sum of RRP and SRP) are shown on the right and indicate that 
although the burst remained constant for wild-type cells, they actually were greater at short 
intervals in the DKO cells. Error bars indicate SEM. 
 
3.2.4 Calcium-sensing does not change in CAPS DKO chromaffin cells 
We tested whether secretion in CAPS DKO cells has a different calcium requirement 
than that of wild-type cells. To this end, we applied a calcium “ramp” stimulus 
(Sorensen et al., 2002), a slowly rising calcium concentration generated by photolysis 
of calcium from NP-EGTA in small increments over a longer time (10 s), as opposed 
to the stepwise increase achieved using a flash lamp. This was done using short 
pulses of UV light of 350 and 380 nm at short intervals. The calcium ramp stimulus 
led to robust secretion (Fig. 7A). The response to the ramp stimulus was sigmoid in 
both the wild-type and CAPS DKO cells (Fig. 7A). Scaling the release response of 
CAPS DKO mice to that of wild-type cells indicated a slightly steeper early rising 
phase in the DKO cells (data not shown). The total secretion in the wild-type cells 
(334.4 ± 32.3 fF; n =16) was approximately four times that in the DKO cells (76.3 ±  
10.8 fF; n = 15). The secretion response in wild-type cells, although sigmoid, was 
best fit with the sum of two sigmoids, whereas the secretion in the CAPS DKO cells 
could be well fit with a single sigmoid curve (Fig. 7A). In the case of the wild-type 
cells, the first component had a midpoint near 5 s and consisted of 198 fF. This 
component likely represents the burst response. The additional secretion is likely 
attributable to sustained release. The sigmoid fit for the CAPS DKO cells had a 
midpoint near 5.6 s and likely consists of only a burst response of ~80 fF. The 
thresholds for calcium induced secretion during the ramp stimulation were similar 
(~800 nM) in wild-type and CAPS DKO cells. We estimated the rate constants for 
secretion (Sorensen et al., 2002), and these are plotted versus the calcium 
concentration in Fig. 7B. For both wild-type and CAPS DKO responses, estimated 
rate constants rose with the calcium concentration and were similar over the entire 
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range tested. Thus, CAPS does not alter calcium sensing during secretion. 
 
Figure 7. The calcium dependence of secretion is unchanged in CAPS DKO chromaffin 
cells.  
A. Ramp-like calcium increases (mean ± SEM; top trace) lead to robust secretion in wild-type 
chromaffin cells (WT;∆Cm). The total mean secretion during the ramp stimulus was 334 fF in 
wild-type cells (n=15) and 76 fF in CAPS DKO cells (n=16). The capacitance trace of wild-type 
cells (gray) was fit with a dual sigmoid curve (overlaid black line), with an early phase (solid line) 
and a later phase (dashed line). The capacitance response of the DKO cells (red trace) was well 
fit with a single sigmoid (overlaid). B. The rate constant of stimulated release (based on the 
capacitance change) was similar in wild-type (black) and CAPS DKO (red) cells. The threshold for 
calcium-dependent secretion was not different. The results show that the calcium dependence of 
secretion is similar in wild-type and CAPS DKO cells and indicate that CAPS does not alter 
calcium sensing in the secretion phase. 
 
3.2.5 Deletion of CAPS-1 and CAPS-2 does not change the fusion kinetics 
To determine whether there were qualitative changes in vesicle fusion, we examined 
the properties of single amperometric events. An example of such an experiment is 
shown in Fig. 8A. There was no significant difference between wild-type and CAPS 
DKO cells in the amplitude, half width, rise time, single spike charge, or “foot” 
parameters of the amperometric events (Fig. 8B–F). The only difference we observed 
between wild-type and CAPS DKO cells in amperometric events was in the frequency 
of events in calcium-perfused chromaffin cells (Fig. 8G), consistent with the 
observations in CAPS-1 knock-out cells, which we have reported previously (Speidel 
et al., 2005), and with reports in PC12 cells after CAPS knockdown (Fujita et al., 
2007). Thus deletion of CAPS-1 and CAPS-2 does not change the fusion kinetics. 
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Figure 8.  Amperometric spike parameters are normal in CAPS DKO chromaffin cells.  
A. Example of amperometric activity during calcium perfusion (~4 µM) in wild-type (top trace) and 
DKO (bottom trace) cells. B–F. There was no difference in the following: the amplitude of 
amperometric responses between wild-type (n=12, 2151 events) and DKO cells (n=10, 479 
events) (B); the half-width of amperometric spikes for DKO cells compared with wild type cells (C); 
the rise time of amperometric responses was similar in wild type and CAPS DKO chromaffin cells 
(D); the catecholamine content of the vesicles was also similar in wild-type and CAPS DKO cells 
(E); the duration of so-called foot events in the CAPS DKO cells compared with those events 
observed in wild-type cells (F). G. There was a strongly significant difference in the frequency of 
amperometric events compared with those observed in wild-type chromaffin cells during calcium 
perfusion (4 µM; ***p<0.001). The mean median values ± SEM are shown. WT, Wild type. 
 
3.3 Restoration of secretion in CAPS DKO cells 
3.3.1 CAPS-1 restores secretion in CAPS DKO chromaffin cells 
To rule out the possibility that our results are an artifact because of secondary 
consequences of the CAPS deletion, we reintroduced CAPS-1 into chromaffin cells 
from CAPS DKO mice, using the Semliki Forest virus expression system. In flash 
experiments, the characteristics of CAPS DKO cells were similar to those described 
above, exhibiting a small burst response of ~47 fF (Fig. 9A) (n=15), with an RRP of 
22.1 ± 5.7 fF, an SRP of 25.2 ± 8.4 fF, and little sustained release (2.4 ± 1.5 fF/s) (Fig. 
9B). Recordings from CAPS DKO cells expressing CAPS-1 showed significantly 
stronger secretion, with a burst that was approximately five times larger than that 
observed in CAPS DKO cells (226 fF; n = 17) (Fig. 9A). The RRP of the DKO cells 
expressing CAPS-1 was 155.6 ± 23 fF, greater than that of the wild-type cells (Fig. 4), 
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whereas the SRP (69.1 ± 8.3 fF) and sustained release (20.9 ± 3.3 fF/s) were similar 
to that observed in wild-type cells (Figs. 4, 9B). The capacitance changes were 
associated with comparable amperometric responses as well (Fig. 10A). This result 
emphasizes the selective effect of CAPS on the filling of the RRP described in Fig. 4 
and 6. The difference in release time constants of the RRP approached significance 
(CAPS DKO, 40 ms; CAPS-1 rescue, 27 ms; p > 0.05), but not in the SRP (CAPS 
DKO, 630 ms; CAPS-1 rescue, 461 ms; p > 0.2). 
 
 
Figure 9. CAPS-1 reintroduction rescues the RRP 
and sustained release in CAPS DKO chromaffin 
cells.  
A. Flash photolysis of NP-EGTA was performed in 
DKO chromaffin cells. These cells were used as 
controls for cells from littermates in which CAPS-1 
was expressed using the Semliki Forest virus as 
vector. DKO cells exhibited low levels of secretion (∆ 
Cm) with no sustained component, whereas 
CAPS-1-expressing cells exhibited approximately 
fivefold secretion and a robust sustained component. 
The calcium levels reached in both groups were 
similar (top trace). The amperometric responses 
(catecholamine release; Iamp) observed during the 
capacitance change was also greatly enhanced after 
CAPS-1 expression.  
B. The mean values ± SEM of the RRP, SRP 
(***p<0.001) and sustained phases in the above 
described rescue experiments. Sust. Rate, sustained 
rate. 
 
 
 
We also tested whether overexpression of CAPS-1 in wild-type mice enhanced 
secretion. The results of this experiment are shown in Fig. 10. CAPS-1 
overexpression in wild-type chromaffin cells led to a modest enhancement of the 
secretory burst and sustained release following photolysis of caged calcium. The 
RRP following CAPS-1 overexpression in wild type cells was 105 ± 16.1 fF compared 
to 79 ± 13.8 fF in control cells (no significant difference). The SRP sizes were 60.8 ± 
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10.7 and 60.7 ± 9.4 fF in CAPS-1 expressing wild-type cells and control cells, 
respectively. The sustained rate was also greater in CAPS-1 expressing cells (26.1 ± 
5.2 fF and 19.1 ± 2.4 fF, CAPS-1 expression, and control, respectively, no significant 
difference). Although the overexpression of CAPS-1 in wild-type cells did not cause a 
significant difference of secretion, it selectively enhanced the RPP size and the 
sustained rate compared to control cells.   
 
 
Figure 10. CAPS-1 enhances secretion in wild-type 
cells.  
A. Overexpression of CAPS-1 in wild-type chromaffin 
cells results in a modest enhancement of secretion.  
B. A modest strengthening of the readily releasable 
pool of vesicles and sustained rate did not reach 
statistical significance. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
3.3.2 CAPS-2 also can rescue the CAPS DKO phenotype 
To test whether CAPS-2 can also rescue the CAPS DKO phenotype, we performed 
CAPS-2 rescue experiments with CAPS DKO chromaffin cells. Expression of 
CAPS-2 in chromaffin cells from CAPS DKO mice resulted in a strong enhancement 
of the secretory burst and of sustained release (Fig. 11). By fitting the capacitance 
increase as the sum of two exponentials and a linear phase, we have estimated the 
size of the readily releasable pool and the slowly releasable pool, their time constants, 
and the rate of the linear sustained phase. The results of this analysis are shown in 
---------- Results ---------- 
65 
Fig. 11B. There was a significant increase in the RRP (42.8 ± 18.6 fF, DKO; 125.3 ± 
25.8 fF, CAPS-2 overexpressing DKO cells, p<0.001, Mann-Whitney U test) with no 
change in its time constant (23.5 ± 5.2 vs. 23.2 ± 1.4 ms), no change in the SRP 
(51.7 ± 12.8 fF, DKO; 51.8 ± 7.5 fF, CAPS2 overexpressing DKO cells), and an 
increase in sustained release which was not measurable in the DKO and 19.2 ± 3.7 
fF/s in the CAPS-2 expressing DKO cells. Thus, as is the case for CAPS-1, 
expression of CAPS-2 in the CAPS DKO cells restores secretion with a selective 
effect on the RRP and the sustained phase. 
 
 
Figure 11. CAPS-2 restores secretion to wild type 
levels in CAPS DKO cells.   
A. Responses to flash photolysis of caged calcium in 
CAPS DKO cells (red; n=19, N=3) and in CAPS DKO 
cells expressing CAPS-2 protein (blue; n=24, N=3). 
The calcium concentration (upper traces), the resulting 
change in membrane capacitance (middle traces) 
show a clear enhancement in those cells expressing 
CAPS-2. Carbon fibre responses to released 
catecholamines (lower traces) to show catecholamine 
release.  
B. Analysis of the kinetics of the capacitance traces 
yield estimates of the releasable pools and the 
sustained release rate. The RRP was strongly 
enhanced by CAPS-2 expression, while there was no 
clear effect on the slowly releasable pool. The rate of 
sustained release in the period in which calcium 
remained elevated was also enhanced following 
CAPS-2 expression. ***p<0.001. 
 
 
 
 
3.3.3 Open syntaxin rescues the RRP but not sustained release in CAPS DKO 
cells 
As CAPS-1 and CAPS-2 both containing a MHD domain facilitate the priming and the 
MHD domain is critical for priming function of Munc13-1, an attractive hypothesis is 
that CAPS carries out its priming function in a fashion similar to that of the Munc-13’s, 
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which bind to the Munc18-syntaxin complex (Betz et al., 1997; Richmond et al., 2001) 
promoting a conformational change in syntaxin, allowing it to engage into the SNARE 
complex (Dulubova et al., 1999). So we tested whether expression of an open form 
of syntaxin (Syntaxin1A - L165A/E166A; (Dulubova et al., 1999)) can reverse the 
CAPS DKO chromaffin cell secretion deficit (Fig. 12A). Expression of open-syntaxin 
in chromaffin cells from CAPS DKO mice led to strongly enhanced secretion (~3 fold 
increase). The enhancement was accounted for by a ~ 3 fold increase in the RRP 
(43.5 ± 8.9 fF, DKO; 129.2 ± 21.8 fF, open-syntaxin expressing DKO cells) (Fig. 12B). 
There was a modest increase in the SRP (52.3 ± 8.9 fF, DKO versus 79.5 ± 11.3 fF 
open-syntaxin expressing DKO cells) but there was virtually no sustained component 
in either group of cells. The lack of a sustained component may be due to exhaustion 
of the UPP since application of a second flash after a two minute recovery period 
resulted in a reduced open-syntaxin response, with a small RRP and no sustained 
component, while in the CAPS DKO cells the response to the second flash was 
equivalent to the first response (Fig. 12C and 12D). The secretory burst in the 
open-syntaxin expressing DKO cells was smaller than that in the DKO cells following 
the second flash application. 
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Figure 12.  Open-syntaxin restores secretion in CAPS DKO cells.  
A. The results of flash photolysis of caged which increases calcium (upper trace) in DKO cells 
(red; n=23, N=5) and DKO cells expressing open-syntaxin (blue; n=24, N=5) show that 
open-syntaxin restores secretion. The burst of secretion is much greater (middle traces) in the 
open syntaxin expressing cells, and the catecholamine release, as integral of the carbon fibre 
response (lower traces) is also strongly enhanced. B. Estimates of the releasable pools and the 
sustained rate indicate that open syntaxin enhances selectively the RRP. Note that there is little 
sustained release following the burst. C. Examination of a second flash stimulation to the same 
cells after a two minute recovery period shows that open syntaxin treated DKO cells recover 
poorly after flash stimulation. D. Pool analysis shows that open-syntaxin expressing DKO cells 
recover more poorly and do not exhibit a greater RRP after a second flash. **p<0.01;***p<0.001. 
 
We next examined the effects of ramp stimulation in DKO cells in which 
open-syntaxin was expressed (Fig. 13). In agreement with the data obtained by flash 
stimulation (Fig. 12) these cells showed strongly enhanced secretion (295.5 ± 38.9 
fF), as compared to that of untreated DKO cells (72.2 ± 13.2 fF, Fig. 13A). There was 
no difference between the calcium concentration threshold for secretion in DKO cells 
and open-syntaxin expressing cells. At the end of the ramp stimulus, a flash is 
applied to test the residual secretory capacity. The response is shown in Fig. 13B. 
The DKO cells secreted slightly more in response to the post-ramp flash, than did the 
open-syntaxin expressing DKO cells. The fraction of the total secretion released in 
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the post-ramp flash was ~64% in the DKO cells and ~25% in the open-syntaxin 
expressing DKO cells. Thus, in the open-syntaxin expressing DKO cells ~ 75% of the 
secretory capacity was released during the ramp stimulation. Only about 36% of the 
secretory capacity was released by the ramp stimulation in the DKO cells. The 
release following the flash stimulation was slow, and similar in both groups, indicating 
that residual release came from a slowly releasable pool of vesicles. The total 
secretion was much greater in the open-syntaxin expressing DKO cells, as was the 
case in the original flash experiments. Thus, though open-syntaxin bypasses the 
requirement for CAPS and generates a pool of vesicles that can be released by ramp 
or flash stimulation, it does not appear to support sustained release. 
 
 
Figure 13.  The response of CAPS DKO cells and those expressing open-syntaxin to 
stimulation of secretion using slowly rising calcium signal.  
A. The free calcium concentration is shown in the upper trace and the capacitance change is 
shown in the lower trace. Those cells expressing open-syntaxin (blue; n=27, N=5) exhibit very 
strong secretion compared to DKO cells not expressing open-syntaxin (red; n=29, N=5). B. In 
order to determine the amount of secretion remaining after the ramp stimulation, a flash was 
applied to increase calcium to high levels. The residual secretion in the CAPS DKOs was larger 
than that of the DKOs expressing open-syntaxin, and accounted for 64% of the total secretion, 
while the flash response in the open-syntaxin expressing DKO cells accounted for about 25% of 
the total secretion.  
 
To test whether the lack of sustained release in open-syntaxin expressing CAPS 
DKO cells is related to CAPS or not, we expressed open-syntaxin in wild-type 
chromaffin cells and compared secretion in these two groups (Fig. 14A). In these 
cells we also observed an increase in the RRP 95.8 ± 9.4 fF versus 209.3 ± 26.0 fF, 2 
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fold increase, wild-type versus open-syntaxin expressing wild-type cells, no 
significant increase in the SRP (101.7 ± 14 fF versus 146.6 ± 25.3 fF, wild type 
versus open-syntaxin expressing wild type, respectively), and a reduction in the 
sustained phase (22.5 ± 3.8 and 4.6 ± 2.1 fF/s, wild type versus open-syntaxin 
expressing wild type, Fig. 14B). These experiments indicate that open-syntaxin 
promotes secretion by selectively enhancing the readily releasable pool, but 
simultaneously reduces sustained release. As in CAPS DKO cells, wild-type cells 
expressing open-syntaxin exhibited only modest pool refilling with a reduction in the 
second flash response (Fig. 14C) and a strong reduction in secretion (RRP, 136.8 ± 
21.5 and 104.6 ± 18.9 fF; SRP 99.8 ± 13.0 and 56.3 ± 10.5 fF; sustained 11.4 ± 2.5 
and 1.6 ± 1.0 fF (Fig. 14D). Thus it appears that open-syntaxin exhausts the 
secretory response and that the effects on sustained release are independent of 
CAPS. 
 
 
Figure 14. Expression of open syntaxin in wild type cells enhances the RRP selectively.  
A. Flash photolysis release of calcium produces a larger burst of secretion in open-syntaxin 
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expressing wild type cells (red; n=24, N=4), when compared to cells not expressing 
open-syntaxin (black; n=22, N=4). This is mirrored in an increase in catecholamine release. B. 
Analysis of the kinetics of the releasable pools and the rate of sustained release show that the 
RRP is strongly enhanced while the SRP is unaltered. The sustained release is reduced. C. 
Examination of a second flash response after a two minute recovery period shows a deficit in 
refilling pools emptied by a flash stimulation in open-syntaxin expressing wild type cells. D. Pool 
analysis for the second stimulation. **p<0.01;***p<0.001. 
 
3.3.4 Rescue of Munc13-1 
3.3.4.1 Munc13-1 expression does not rescue the CAPS DKO phenotype 
The above results indicate that CAPS exerts its function in LDCV priming through the 
opening of syntaxin, thus enabling syntaxin to engage in SNARE complex formation. 
The MHD domain of CAPS may be involved in the conformational change of syntaxin 
required for priming, as is believed to be the case for the MHD domains of Munc13 in 
synaptic vesicle release (Basu et al., 2005; Madison et al., 2005; Stevens et al., 
2005). If this is indeed the case, rapid secretion in chromaffin cells from CAPS DKO 
mice should also be restored by expression of Munc13-1. Surprisingly, expression of 
a full-length Munc13-1-GFP construct in CAPS DKO cells failed to restore normal 
secretion (Fig. 15A). Actually, there was a decrease in all phases of flash-induced 
secretion in DKO cells expressing Munc13-1 (RRP, 48.4 ± 12.8 and 31.1 ± 8.5, DKO 
and Munc13-1 expression in DKO respectively; SRP, 58.1 ± 10.0, 24.7 ± 5.6, DKO 
and Munc13-1 expression, respectively; sustained, 2.9 ± 1.6, 1.9 ± 1.0, DKO and 
Munc13-1 expression, respectively; Fig. 15B).  
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Figure 15. Expression of Munc13-1 does 
not enhance secretion in CAPS DKO 
chromaffin cells.  
A. The free calcium (upper trace), the 
capacitance changes (middle traces) and the 
amperometric recordings (lower traces) show 
that Munc13-1 expression (blue; n=23, N=5) 
did not restore release to wild type levels in 
CAPS DKO cells (red; n=22, N=4).   
B. Estimates of the kinetic parameters show 
that all phases were suppressed in cells 
expressing Munc13-1. **p<0.01. 
 
3.3.4.2 Munc13-1 enhances exocytosis in CAPS1+-/CAPS2-- cells 
Since expression of Munc13-1 strongly enhance secretion in wild type chromaffin 
cells, we considered whether the lack of enhanced secretion in CAPS DKO cells 
following Munc13-1 expression may be directly related to the lack of CAPS. We 
therefore examined the ability of full length Munc13-1 to enhance secretion in cells 
from CAPS1 +/- CAPS2 -/- mice (Fig. 16A). In these cells Munc13-1 expression 
enhanced all phases of secretion significantly (RRP, 145.8 ± 19 fF and 281.5 ± 39.9 
fF; SRP, 82.5 ± 10.0 fF and 278.3 ± 44.0 fF; sustained, 20.0 ± 3.3 fF/s and 50.7 ± 7.2 
fF/s; CAPS1+/- CAPS2-/- and CAPS1+/- CAPS2-/- expressing Munc13-1, 
respectively, Fig. 16B). 
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Figure 16. Munc13-1 enhances the secretion in 
CAPS1+-/CAPS2-- cells.  
A. Munc13-1 overexpression in CAPS heterozygotes 
has the expected effect on secretion. Secretion was 
enhanced in CAPS-1 heterozygotes expressing 
Munc13-1 (red; n=25, N=5), when compared to 
CAPS-1 heterozygotes not expressing Munc13-1 
(black; n=23, N=5).  
B. Analysis of the kinetics of capacitance responses 
show that Munc13-1 enhances all phases of the 
response in CAPS-1 expressing chromaffin cells. 
**p<0.01;***p<0.001. 
 
 
 
 
 
 
 
 
 
3.3.4.3 Munc13-1 does not enhance the exocytosis when CAPS-1 is missing 
We then examined the effect of expression of Munc13-1 in cells in which CAPS1 was 
deleted but which had one intact allele of CAPS-2. In these cells, Munc13-1 failed to 
enhance secretion, and, as in the DKO cells, there was a depression of release (Fig. 
17A), associated with no clear change in the relationship in releasable pools (RRP, 
98.8 ± 12.4 fF and 72.8 ± 16.6 fF; SRP, 50.3 ± 7.5 fF and 33.8 ± 5.7 fF; sustained, 
9.2 ± 2.4 fF/s and 6.3 ± 2.2 fF/s; CAPS1-/- CAPS2+/- and CAPS1-/- CAPS2+/- 
expressing Munc13-1, respectively, Fig. 17B). Expression of Munc13-1 in wild type 
cells resulted in the expected robust enhancement of all phases of secretion. Thus it 
appears that in the absence of CAPS-1, Munc13-1 does not enhance secretion while 
in cells expressing CAPS-1, expression of Munc13-1 causes an enhancement of all 
secretory phases. Fig. 17C shows a summary of the effects of Munc13-1 expression 
on the secretory burst in these experiments. This indicates an interaction between 
CAPS-1 and Munc13-1 in the priming process of chromaffin cells. 
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Figure 17. Munc13-1 does not enhance secretion in cells which do not express CAPS-1, 
even when the gene for CAPS-2 is functional.  
A. Responses to flash photolysis in CAPS-1 deletion cells having one functional CAPS-2 allele. 
Munc13-1 expressing cells (red; n=23, N=5), in spite of slightly higher resting calcium 
concentrations (upper trace) secreted less than did cells from CAPS1--/CAPS2+- (black; n=22, 
N=5) littermates (middle trace). The catecholamine release results are consistent with the 
capacitance data (lower trace). B. The kinetic analysis of flash responses demonstrates that 
Munc13-1 did not enhance any component of the responses. C. Summary of the results of 
expressing Munc13-1 in chromaffin cells. In the DKO and in the CAPS1--/CAPS2+- cells, 
Munc13-1 expression failed to enhance responses while in CAPS1+-/CAPS2-- cells and in wild 
type cells, expression of munc13-1 produced a robust enhancement of secretion. 
 
3.3.5 Treatment with PMA but not Forskolin enhances the secretion in CAPS 
DKO chromaffin cells  
PMA induces the augmentation of neurotransmitter release through Munc13-1 and 
via a PKC-dependent pathway (Gillis et al., 1996; Rhee et al., 2002). Forskolin 
activates the PKA pathway to regulate the neurosecretion (Nagy et al., 2004). 
Previous reports show that application of phorbol esters rescues the neurotransmitter 
release from CAPS deficient hippocampal neurons to wild-type level (Jockusch et al., 
2007). However in C.elegans Forskolin, but not phobol esters can bypass the 
requirement of UNC-31 for LDCVs exocytosis (Zhou et al., 2007). We tested whether 
the application of PMA(a phobor ester) and Forskolin enhance the secretion from 
chromaffin cells when CAPS is missing. PMA (500 nM) was added into the 
extracellular solution. Forskolin (50 µM) was perfused into the CAPS DKO cell 
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through the glass pipette. A train of depolarizations from -70 mV to 20 mV at 3 HZ is 
applied to stimulate the catecholamine release. The results are shown in Fig. 18. 
PMA treatment causes an increase of the secretion while Forskolin induces a modest 
reduction of secretion compared to CAPS DKO cells (113.6 fF from CAPS DKO cells; 
164.3 fF from PMA treated DKO cells; 102.4 fF from Forskolin treated DKO cells). 
The calcium inward currents are comparable in all three groups suggesting that the 
difference of secretion is not due to the different calcium influx. PMA, but not 
Forskolin, enhanced the secretion from CAPS DKO cells indicates that the deficit of 
secretion in CAPS DKO cells can be reversed through Munc13-1 or PKC-dependent 
pathway but not PKA-dependent pathway. 
 
 
Figure 18. PMA treatment enhances the secretory 
response of chromaffin cells from CAPS DKO 
mice.  
A. The schematic graph of the stimulation protocol 
consisting of six 10 ms depolarizations followed by four 
100 ms depolarizations with 300 ms interval.  
B. Averaged peak values of Ca2+ current (Ica) are 
shown (mean ± SEM).  
C. Averaged capacitance trace (∆Cm) in response to 
the depolarization protocol. PMA (500 nM) treated 
CAPS DKO cells (blue; n=21, N=3) exhibit larger 
secretion than that of DKO cells (red; n=22, N=3), 
while Forskolin (50 µM) treatment (green; n=19, N=3) 
does not enhance the secretion of CAPS DKO cells.   
 
3.3.6 CAPS-1 deletion mutant does not rescue the CAPS DKO phenotype 
The above results suggest a priming function for CAPS which is mechanistically 
similar to that of Munc13’s. Therefore, we tested whether the putative MUN domain 
of CAPS is sufficient to prime LDCVs in chromaffin cells by expressing deletion 
constructs of CAPS in which the proposed MUN domain remains intact. An 
N-terminal deletion of the first 200 amino-acids of CAPS-1 failed to enhance 
secretion in CAPS DKO chromaffin cells (Fig. 19A). The expression of this construct 
in CAPS DKOs led to a modest reduction in secretion associated with a slight 
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decrease in the SRP size (RRP, 45.0 ± 7.2 fF and 41.6 ± 5.4 fF; SRP, 51.9 ± 6.0 fF 
and 34.1 ± 5.1 fF; sustained, 2.3 ± 1.2 fF/s and 3.8 ± 1.3 fF/s; CAPS DKO and CAPS 
DKO expressing deletion construct, respectively, Fig. 19B). So N-terminal of CAPS 
may contain the information for CAPS sorting and localization thus is important for 
CAPS function.  
 
 
Figure 19. N-terminal 200 amino-acids deletion 
mutant of CAPS-1 does not retain the function.  
A. Averaged [Ca2+]i (upper trace), capacitance change 
(∆Cm, middle trace) and amperometric response (Iamp, 
lower trace) from flash photolysis experiments are 
shown. The secretion of CAPS DKO cells expressing 
deletion mutant (green; n=23, N=5) is slightly smaller 
than that of DKO cells (red; n=23, N=5).  
B. The SRP size is significantly reduced (*, p<0.05) in 
deletion mutant expressing DKO cells compared to 
DKO cells. The RRP size and sustained rate are 
comparable in two groups.  
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Table 1. Detailed parameters of flash photolysis experiments 
 
Flash experiments n 
Pre-flash 
[Ca2+]i 
(nM) 
Post-flash 
[Ca2+]i 
(µM) 
RRP 
(fF) 
SRP 
(fF) 
Sustained 
rate 
(fF/s) 
τRRP 
(ms) 
τSRP 
(ms) 
WT 23 350.3 ± 17.6 24.2 ± 2.5 99.5 ± 17.5 123.9 ± 19.6 19.8 ± 3.1 30.1 ± 4.7 612.7 ± 186.7 
CAPS-2 KO 23 337.8 ± 18.6 22.2 ± 2.0 88.5 ± 9.2 95.8 ± 19.6 17.4 ± 2.0 28.8 ± 4.0 590.4 ± 125.3 
WT 30 454.0 ± 28.4 23.9 ± 1.5 65.4 ± 8.3 88.0 ± 17.3 19.5 ± 2.2 28.7 ± 8.6 400.5 ± 54.7 
CAPS DKO    29 435.2 ± 20.6 25.9 ± 1.8 31.3 ± 9.8 70.5 ± 14.5 0.5 ± 2.1 55.8 ± 15.3 500.4 ± 51.2 
CAPS DKO 
10s ISI first flash 
20 593.4 ± 69.8 17.4 ± 1.2 26.0 ± 4.5 28.2 ± 5.5 1.2 ± 1.1 44.7 ± 12.8 609.3 ± 157.1 
WT 
10s ISI first flash 
19 577.8 ± 52.5 18.5 ± 0.7 74.1 ± 10.6 52.8 ± 7.0 20.3 ± 3.2 35.6 ± 9.0 734.1 ± 261.4 
CAPS DKO 
10s ISI second flash 
19 2.8 ± 0.3(µM) 28.1 ± 0.7 1.6 ± 4.5 89.5 ± 12.5 0 ± 0 23.4 ± 2.3 430.5 ± 51.3 
WT 
10s ISI second flash 
19 2.4 ± 0.2(µM) 28.6 ± 0.6 35.5 ± 11.7 98.3 ± 11.0 20.3 ± 3.2 47.6 ± 20.8 529.2 ± 135.4 
CAPS DKO 
20s ISI first flash 
25 428.8 ± 28.4 17.3 ± 0.7 26.5 ± 6.1 31.2 ± 7.4 1.8 ± 0.6 29.4 ± 4.7 619.3 ± 152.0 
WT 
20s ISI first flash 
25 398.7 ± 16.1 16.7 ± 0.5 77.7 ± 7.2 77.4 ± 7.4 18.0 ± 2.7 30.0 ± 3.0 702.5 ± 127.3 
CAPS DKO 
20s ISI second flash 
24 1.1 ± 0.1(µM) 24.0 ± 0.7 8.5 ± 3.6 73.2 ± 12.3 0 ± 0 41.2 ± 16.0 411.7 ± 69.5 
WT 
20s ISI second flash 
25 0.9 ± 0.1(µM) 23.2 ± 0.5 51.0 ± 10.3 115.7 ± 10.2 7.1 ± 4.1 30.0 ± 4.9 562.8 ± 82.5 
CAPS DKO 
40s ISI first flash 
15 407.2 ± 33.6 16.8 ± 1.0 24.2 ± 4.6 29.3 ± 11.0 0.8 ± 1.2 30.6 ± 4.9 578.5 ± 117.6 
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WT40s ISI first flash 12 382.6 ± 24.7 17.3 ± 0.8 71.2 ± 16.3 65.2 ± 15.0 17.0 ± 2.2 32.5 ± 6.4 502.8 ± 144.7 
CAPS DKO 
40s ISI second flash 
13 524.3 ± 52.8 19.5 ± 0.9 11.5 ± 1.8 34.1 ± 10.1 0 ± 0 29.3 ± 5.0 663.4 ± 186.7 
WT 
40s ISI second flash 
13 479.9 ± 28.5 18.7 ± 0.7 61.6 ± 10.1 74.2 ± 10.8 6.1 ± 2.4 37.7 ± 5.9 634.6 ± 161.0 
CAPS DKO    15 597.1 ± 58.5 21.9 ± 1.4 22.1 ± 5.7 25.2 ± 8.4 2.4 ± 1.5 40.0 ± 2.0 630.0 ± 27.6 
CAPS-1 rescue    17 694.5 ± 71.1 24.0 ± 1.5 155.6 ± 23.0 69.1 ± 8.3 20.9 ± 3.3 26.7 ± 3.0 461.0 ± 13.0 
CAPS DKO 19 541.3 ± 43.5 23.2 ± 1.1 42.8 ± 18.6 51.7 ± 12.2 0 ± 0 23.5 ± 5.2 532.9 ± 14.4 
CAPS-2 rescue 24 479.6 ± 36.1 21.1 ± 1.0 125.3 ± 25.8 51.8 ± 7.5 19.2 ± 3.7 23.2 ± 1.4 401.9 ± 10.8 
WT 26 428.9 ± 26.1 20.0 ± 0.7 79.0 ± 13.8 60.8 ± 10.7 19.1 ± 2.4 30.6 ± 2.7 505.2 ± 41.5 
CAPS-1 in WT 24 565.0 ± 47.1 23.1 ± 0.9 105.0 ± 16.1 60.7 ± 9.4 26.1 ± 5.2 23.5 ± 2.7 579.2 ± 140.0 
CAPS DKO first flash 23 647.4 ± 90.9 26.3 ± 1.3 48.5 ± 11.9 53.9 ± 8.9 1.4 ± 1.0 24.3 ± 12.0 258.6 ± 37.2 
Open syntaxin in CAPS DKO 
 first flash 
24 604.2 ± 69.1 21.0 ± 1.0 129.2 ± 21.8 79.5 ± 11.3 1.1 ± 1.5 34.4 ± 9.0 300.0 ± 41.9 
CAPS DKO second flash 20 641.0 ± 106.0 25.6 ± 1.6 42.0 ± 7.5 58.0 ± 7.6 0.2 ± 1.9 28.9 ± 4.1 330.2 ± 54.0 
Open syntaxin in CAPS DKO  
second flash 
17 553.9 ± 49.5 20.7 ± 1.0 35.9 ± 11.2 32.6 ± 11.7 3.1 ± 1.2 22.6 ± 4.0 259.5 ± 59.6 
WT first flash 24 501.2 ± 34.3 22.0 ± 0.9 95.8 ± 9.4 101.7 ± 14.0 22.5 ± 3.8 19.7 ± 1.6 459.1 ± 68.7 
Open syntaxin in WT  
first flash 
22 434.3 ± 34.2 19.2 ± 1.0 209.3 ± 26.0 146.6 ± 25.3 4.6 ± 2.1 35.1 ± 5.5 338.4 ± 42.4 
WT second flash 18 510.5 ± 41.5 22.2 ± 1.1 136.8 ± 21.5 99.8 ± 13.0 11.4 ± 2.5 33.7 ± 4.6 293.2 ± 47.9 
Open syntaxin in WT second Flash 20 578.2 ± 122.4 20.9 ± 1.7 104.6 ± 18.9 56.3 ± 10.5 1.6 ± 1.0 34.9 ± 5.6 389.2 ± 54.5 
CAPS DKO 22 575.8 ± 45.6 23.9 ± 1.2 48.4 ± 12.8 58.1 ± 10.0 2.9 ± 1.6 19.7 ± 4.0 324.7 ± 51.3 
Munc13-1 in CAPS DKO 23 499.2 ± 48.2 21.5 ± 1.4 31.1 ± 8.5 24.7 ± 5.6 1.9 ± 1.0 22.9 ± 5.2 792.7 ± 193.8 
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CAPS1+-/CAPS2-- 23 359.7 ± 45.7 21.0 ± 1.0 145.8 ± 19.0 82.5 ± 10.0 20.0 ± 3.3 22.9 ± 3.1 519.2 ± 8.2 
Munc13-1 in CAPS1+-/CAPS2-- 25 360.7 ± 47.2 20.6 ± 1.0 281.5 ± 39.9 278.3 ± 44.0 50.7 ± 7.2 22.5 ± 2.5 1038.7 ± 214.4 
CAPS1--/CAPS2+- 22 210.8 ± 36.7 17.0 ± 0.9 98.8 ± 12.4 50.3 ± 7.5 9.2 ± 2.4 27.4 ± 3.3 376.0 ± 42.0 
Munc13-1 in 
 CAPS1--/CAPS2+- 
23 399.3 ± 46.5 23.2 ± 0.9 72.8 ± 16.6 33.8 ± 5.7 6.3 ± 2.2 21.9 ± 3.4 474.7 ± 37.6 
CAPS DKO 23 619.3 ± 90.4 24.4 ± 1.2 45.0 ± 7.2 51.9 ± 6.0 2.3 ± 1.2 31.6 ± 5.5 435.4 ± 43.9 
200-1256 Deletion construct in 
CAPS DKO 
23 674.8 ± 96.6 22.1 ± 1.4 41.6 ± 5.4 34.1 ± 5.1 3.8 ± 1.3 30.8 ± 6.6 476.1 ± 104.1 
 
 
Table 2. Properties of individual fusion events measured by amperometry 
 
 n 
Events 
frequency 
(1/s) 
Charge 
(fC) 
Amplitude 
(pA) 
Rise time 
(ms) 
Half-width 
(ms) 
Foot 
amplitude 
(pA) 
Foot 
duration 
(ms) 
Foot charge 
(fC) 
WT 16 1.8 ± 0.2 88.5 ± 6.3 12.9 ± 1.8 0.69 ± 0.08 5.5 ± 0.5 1.4 ± 0.2 3.3 ± 0.4 3.1 ± 0.7 
CAPS-2 KO 14 1.6 ± 0.2 102.2 ± 9.2 15.2 ± 2.0 0.63 ± 0.05 4.7 ± 0.3 1.6 ± 0.2 3.7 ± 0.6 3.4 ± 0.7 
WT 12 1.7 ± 0.19 74.7 ± 4.6 12.3 ± 1.3 0.71 ± 0.10 4.5 ± 0.5 1.4 ± 0.2 3.2 ± 0.4 2.7 ± 0.5 
CAPS DKO 10 0.54 ± 0.08 76.3 ± 10.0 10.2 ± 1.3 0.66 ± 0.08 5.1 ± 0.3 1.1 ± 0.2 3.1 ± 0.6 2.0 ± 0.5 
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4 Discussion 
Studies in last twenty years provide detailed insight into the regulation of 
neurotransmitter release. It has been widely accepted that the SNARE complex is the 
core machinery of membrane fusion. Many proteins are involved to control the 
assembly of the SNARE complex and regulate the membrane fusion. CAPS 
(Ca2+-dependent activator protein for secretion) is found as a soluble factor that 
reconstitutes calcium-dependent secretion in permeabilized PC 12 cells. Disturbance 
of CAPS leads to motor and nervous system defects indicating an important role of 
CAPS in LDCVs and SVs exocytosis. However at which step in the secretory 
pathway CAPS functions is still unknown. In the present work, we take the advantage 
of CAPS knockout mice, investigated the role of CAPS in mouse adrenal medulla 
chromaffin cells using morphological and electrophysiological assays. 
4.1 Deletion of CAPS-2 does not change the secretion 
Mammals express two CAPS isoforms which are highly homologous to UNC-31 and 
contain a coiled-coil domain (Munc13 homology domain, MHD) with similarity to 
UNC-13/Munc-13. As UNC-13/Munc-13 functions in priming of synaptic vesicles and 
secretory granules and the presence of a region containing two MHDs is critical for its 
priming action, CAPS has a conserved MHD, raising the possibility that CAPS 
functions similarly to UNC-13/Munc-13. Previous studies in permeabilized PC12 cells 
show that CAPS is required for ATP dependent priming in LDCV secretion (Berwin et 
al., 1998; Grishanin et al., 2004). Deletion of CAPS-1 causes a deficit in 
catecholamine secretion from mouse chromaffin cells and leads to fusion of LDCVs 
containing no catecholamines indicating a role of CAPS-1 in catecholamine loading 
as well as in secretion (Speidel et al., 2005). We have now examined the secretion 
from CAPS-2 knockout mice chromaffin cells using flash photolysis and 
amperometric techniques. Results from flash photolysis experiments show that the 
absence of CAPS-2 does not cause a change of the secretion. Ramp experiments 
also show that the secretion of CAPS-2 knockout chromaffin cells is comparable with 
that of wild-type cells, and indicate that Ca2+-sensitivity of secretion is unchanged 
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when CAPS-2 is missing. We examined the kinetics of single vesicle fusion using 
carbon-fibre electrode. No significant difference of properties of single amperometric 
spikes was found. Since CAPS-1 and CAPS-2 are highly homologous and both are 
present in mouse chromaffin cells, the phenotype observed from CAPS-1 or CAPS-2 
single knockout mouse chromaffin cells was probably mitigated by the presence of 
another CAPS isoform. To get a better understanding of CAPS function, CAPS DKO 
mice were required. 
4.2 CAPS facilitates the filling of the rapidly releasable pool  
We have examined catecholamine secretion in mouse chromaffin cells deficient in 
both CAPS-1 and CAPS-2. Mouse chromaffin cells from which both CAPS-1 and 
CAPS-2 are deleted exhibit a large deficit in exocytosis, with a pronounced deficit in 
the RRP, whereas the deficit in the SRP is not statistically significant. The sustained 
rate of release, which reflects the refilling of the readily releasable pool under 
elevated Ca2+, is dramatically depressed in CAPS DKO cells. The reduction of the 
readily releasable pool and the sustained release rate in CAPS DKO cells could be 
due to either a deficit in vesicle docking or priming. Because we observed no 
difference in vesicle density or distribution, or in the number of morphologically 
docked vesicles, we conclude that there is a specific deficit in priming in CAPS DKO 
cells. 
Our dual flash experiments indicate that while refilling occurs, recovery of the RRP 
following strong secretory activity was greatly reduced in CAPS DKO cell as 
compared to wild type cells. Surprisingly, SRP filling approaches wild type levels at 
short intervals, indicating that priming into the SRP proceeds normally in CAPS DKO 
cells. In spite of filling of the SRP, the RRP does not adequately refill. Since the burst 
size at interstimulus intervals (ISIs) of two minutes or 45 s is smaller than that at an 
ISI of 15 s in CAPS DKO cells, and the RRP is not refilled at 45 s. This may result 
from unpriming in mutant cells. 
A defect in priming from the SRP to the RRP, or a lack of stability of the RRP could 
explain this result and the lack of RRP refilling, as well as the decrease in secretory 
burst size in CAPS DKO cells. Thus, in wild type cells the secretory burst (i.e. the 
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sum of SRP and RRP) remains relatively constant while in CAPS DKO cells the burst 
at an ISI of 15 s is larger than that after a 25 s or 45 s ISI. A similar increase in SRP 
in wild type cells is translated into a filled RRP, as the decrease in SRP over time is 
similar to the gain in the RRP, while only about 50 % of the decrease in SRP in CAPS 
DKO cells is translated into a gain in RRP. Thus, in the absence of CAPS, vesicles 
primed to the SRP are lost without being secreted. Although pool refilling occurs in 
CAPS DKO cells, there is little sustained release at intracellular calcium levels which 
normally would release primed vesicles. This is underscored by the lack of sustained 
secretion in spite of overfilling of the SRP, which can be explained if sustained 
release comes from the RRP rather than from the SRP. We cannot rule out that 
sustained release is masked to a degree by endocytosis. 
Our data indicate that CAPS is a priming factor favouring the filling of RRP, consistent 
with the recent reports that CAPS is critical for vesicle priming in hippocampal 
neurons, pancreatic β-cells and PC12 cells (Fujita et al., 2007; Jockusch et al., 2007; 
Speidel et al., 2008). However the lack of a change in morphologically docked 
vesicles and the efficient filling of the SRP in CAPS DKO cells are not consistent with 
a deficit in docking observed in C. elegans neurons (Hammarlund et al., 2008; Zhou 
et al., 2007). The distinct conclusions about CAPS function may arise from the 
different definitions of docking and priming. Docked vesicles are defined by the close 
apposition to the plasma membrane and a fraction of docked vesicles have 
undergone the priming process to be release competent. Hammarlund et al. counted 
the vesicles without a measureable distance between vesicles and plasma 
membrane as docked vesicles. This criterion of docking is so strict that the number of 
docked vesicles maybe underestimated. It is also possible that the requirement for 
visible contact with the membrane selects a subset of docked vesicles which are also 
primed. We have examined the cumulative distribution of distance between vesicles 
and plasma membrane in CAPS DKO and wild-type cells. The comparable distance 
distributions in both groups indicate that the deficit of exocytosis in CAPS DKO cells 
can not be due to a defect of docking, indicating that CAPS is a priming factor.  
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4.3 Calcium sensitivity and fusion kinetics in CAPS DKO cells 
The calcium-dependence of release, as determined by calcium ramp stimulation, is 
the same in DKO cells and wild type cells. As in the flash experiments, the ramp 
stimulation caused robust secretion in wild type chromaffin cells. Secretion in the 
CAPS DKO cells during the ramp stimulation was ~20 % of that observed in wild type 
cells, a greater deficit than that observed in the flash experiments (~46 %). In ramp 
experiments, the total burst in the CAPS DKO cells was ~80 fF, while the burst in the 
wild type cells was about 200 fF, similar to those observed in flash experiments. The 
ratio of wild type burst size to that of the DKO was ~ 2.5, also similar to that observed 
in the flash experiment (~2). As the calcium concentration reached in the ramp 
protocol is similar to that achieved after the flash, the greater decrease in net 
secretion observed in CAPS DKO cells after ramp stimulation is likely due to a lack of 
sustained release in the DKO.  
The chromaffin granule priming process is calcium-dependent, with an estimated Kd 
for calcium of 2.3 µM (Moser and Neher, 1997). Thus, priming is promoted at 
increased intracellular calcium levels. In hippocampal neurons lacking CAPS, deficits 
in glutamatergic neurotransmission can be partially reversed by increasing 
extracellular calcium (Jockusch et al., 2007). However it is not clear whether this 
enhancement of secretion under high calcium is due to the change of calcium 
dependence for release or for priming. In our experiments we show that the calcium 
sensing for release does not change in CAPS DKO cells. The lack of sustained 
release and the greater deficit in ramp experiments may indicate that the 
calcium-dependence of priming is impaired in the absence of CAPS. CAPS is thought 
to function in a calcium-dependent manner, and thus is likely more effective at higher 
calcium concentrations. If CAPS favours RRP priming and is involved in the 
calcium-dependent enhancement of priming, both enhancement of the RRP and 
sustained release could be explained. 
We have examined the fusion parameters in CAPS DKO cells using carbon fibre 
electrodes. No significant difference in the kinetic properties of single granule fusion 
events were found after the detailed analysis of spike charge, amplitude, half-width, 
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50-90% rising time and foot duration. This fits with the previous reports in CAPS-1 
knockout cells and in CAPS knockdown PC12 cells (Fujita et al., 2007; Speidel et al., 
2005) but is not consistent with the previous report from (Elhamdani et al., 1999). 
They perfused CAPS antibody into calf adrenal chromaffin cells via a patch pipette 
and tested the kinetics of catecholamine secretion using amperometric technique. 
Their results suggest that CAPS regulates the fusion pore dilation of LDCVs to the 
plasma membrane. The discrepancy is likely because they used antibody which may 
bind with CAPS localized to the vesicle membrane causing the fusion pore effect. In 
our experiments, genetic deletion was used to inactivate CAPS. Our results indicate 
absence of CAPS does not change the fusion kinetics. 
4.4 Either CAPS-1 or CAPS-2 expression rescue CAPS DKO 
phenotype 
Expression of either CAPS-1 or CAPS-2 in the CAPS-DKO cells rescued the RRP, 
the SRP and sustained release, with a more pronounced effect on the RRP. This 
finding indicates that the observed deficits are due to the lack of CAPS, and not to 
indirect effects of the CAPS loss, e.g. on cell differentiation and development, and 
that CAPS in chromaffin cells facilitates the filling of the RRP and supports sustained 
release. It also indicates that both CAPS isoforms have similar activity and both can 
replace deleted CAPS proteins. The preferential effect on the RRP is consistent with 
a post docking effect, since, in the currently accepted linear priming pathway, 
increased docking will not selectively enhance the RRP. 
CAPS-1 and CAPS-2 are highly homologous, sharing very similar domain structures. 
Overexpression of CAPS-1 or CAPS-2 in permeabilized PC12 cells reconstituted the 
Ca2+-triggered LDCV exocytosis to similar levels indicating that CAPS-1 and CAPS-2 
are functionally equivalent in Ca2+-dependent LDCV exocytosis (Speidel et al., 2003). 
This fits with our observations that CAPS-1 and CAPS-2 have similar activity. 
However CAPS-1 and CAPS-2 exhibit distinct spatial and developmental expression 
patterns. The expression level of CAPS-2 is more constant than CAPS-1 during 
development. CAPS-1 is exclusively expressed in brain and neuroendocrine tissues 
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and CAPS-2 is also found in other tissues. Immunostaining studies in mouse 
chromaffin cells show that CAPS-1 and CAPS-2 are localized to different populations 
of LDCVs (Speidel et al., 2003). Deletion of CAPS-1 but not CAPS-2 induces the 
perinatally lethal phenotype. Expression of CAPS-1 in CAPS DKO cells enhances the 
size of the SRP, while expression of CAPS-2 does not. All above results indicate that 
there is subtle functional difference between CAPS-1 and CAPS-2. Experiments form 
mouse pancreatic β-cells show that the size of the RRP is similarly affected whereas 
the morphologically docked pool is differentially reduced in CAPS-2 KO and 
CAPS-1+-/CAPS-2-- β-cells. It was suggested that CAPS-1 regulates the movements 
of secretory granules towards the plasma membrane and CAPS-2 is involved in the 
maintenance of the RRP (Speidel et al., 2008). The differential regulation of 
exocytosis by CAPS-1 and CAPS-2 may be caused by either distinct Ca2+ affinities or 
compartmentalization within cells. These results suggest distinct roles of CAPS-1 and 
CAPS-2 in β-cells but are not consistent with our oberservations that deletion of 
CAPS does not change the morphological docking of LDCVs in chromaffin cells. Our 
data suggest that only when CAPS-1 is present overexpression of Munc13-1 cause 
an enhancement of secretion in mouse chromaffin cells. This leads to the possibility 
that Munc13-1 selectively interacts with CAPS-1 but not CAPS-2. The reason for this 
is still not clear. Further investigation in neuronal development and molecular 
mechanism of CAPS function might provide new insight into this issue. 
An N-terminal deletion mutant of CAPS-1 failed to rescue the secretion in CAPS DKO 
cells. This is consistent with the previous findings that there is a N-terminal dynactin 1 
binding domain (DBD) which is required for CAPS protein sorting (Sadakata et al., 
2007) and phosphorylation of N-terminal Ser-5, -6 and -7 is necessary for CAPS 
activity (Nojiri et al., 2009). Deletion of N-terminal 200 amino-acids might cause 
improper sorting of CAPS protein or the lack of phosphorylation sites and block the 
activity of CAPS. James et al. examined whether the PH domain or the MHD domain 
of CAPS is sufficient to stimulate liposome fusion as the full length CAPS did. Both 
fragments failed to stimulate the liposome fusion even at high concentration, 
indicating that full length CAPS is required for the function of CAPS (James et al., 
2008, 2009). This could also explain why the deletion mutant of CAPS-1 does not 
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rescue the CAPS DKO phenotype. 
4.5 Interaction between CAPS, syntaxin and Munc13-1 
Expression of a constitutively open syntaxin mutant (open-syntaxin, (Dulubova et al., 
1999)) reversed the RRP deficit in CAPS DKO cells in flash photolysis experiments, 
although sustained release remained suppressed. The lack of sustained release in 
the open-syntaxin expressing cells may be due to the reported docking deficit 
(Gerber et al., 2008). It is unrelated to the absence of CAPS, since it also occurs in 
wild type chromaffin cells. 
When secretion in open-syntaxin expressing cells was stimulated using a calcium 
ramp, there was a ~4-fold increase in secretion during the stimulus compared to that 
in the CAPS DKO cells. A flash application following the ramp showed that residual 
secretion was slightly greater in the CAPS DKO cells than in open-syntaxin 
expressing cells. Though the apparent reluctance of the pools to empty in DKO cells 
may indicate a higher calcium requirement for the SRP, it is more likely due to more 
rapid exhaustion of the pools in open-syntaxin expressing cells, with secretion in 
response to the post-ramp flash consisting of slowly releasable vesicles. 
Since CAPS shares an RRP-enhancing effect with open-syntaxin, it may well function 
to open syntaxin (Richmond et al., 2001). Open-syntaxin rescues the locomotion 
defects in C. elegans unc-31 mutants and the vesicle docking defect that is 
detectable in high-pressure frozen EM samples of these mutants (Hammarlund et al., 
2008; Zhou et al., 2007) but rescue of transmitter release defects was not tested in 
these studies. The highly restricted definition of morphological docking used in this 
study may be a structural correlate of functional priming. 
In light of the effects of open-syntaxin, we expected that Munc13-1 expression would 
also reverse the priming deficits in the CAPS DKO. Introduction of Munc13-1 failed to 
enhance pool size in CAPS DKO cells and actually led to reduced secretion. Since 
Munc13-1 strongly enhanced secretion in CAPS-1 heterozygotes and CAPS-2 KOs, 
it appears that exogenous Munc13-1 cannot prime in the absence of CAPS-1. This 
may indicate a functional interaction between CAPSs and Munc13s. Such an 
interaction has been suggested to occur in mouse hippocampal neurons (Jockusch et 
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al., 2007), where overexpression of Munc13-1 also failed to reverse deficits in 
synaptic transmission in CAPS DKO neurons, although in these cells Munc13 
apparently still functioned in priming, based on the ability of phorbol esters and 
calcium to enhance the remaining priming and transmitter release in CAPS DKO 
cells. Interestingly, also in C. elegans neurons, dense-core vesicle secretion, which is 
strongly CAPS dependent, is enhanced by phorbol esters, but only when CAPS is 
present (Zhou et al., 2007). Open syntaxin expression enhanced the RRP selectively, 
as does CAPS, while expression of Munc13-1 (in the presence of CAPS1) led to a 
non-selective enhancement of secretion from both the SRP and the RRP. This 
indicates that Munc13-1 acts upstream of CAPS and that opening of syntaxin may 
also involve CAPS. The effects on sustained release indicate a role for CAPS in 
Ca2+-dependent priming. An interaction of CAPS with syntaxin has recently been 
reported (James et al., 2009) in a study showing that the fusogenic effect of CAPS in 
a SNARE complex-dependent liposome fusion assay is inhibited by a soluble 
syntaxin fragment and that CAPS binds to syntaxin containing SNAREs as well as to 
syntaxin alone. This function of CAPS appears to result in enhanced SNARE 
complex formation, which would be congruent with our results indicating a combined 
Munc13/CAPS function. 
4.6 Outlook  
CAPS is found on LDCVs of chromaffin cells (Speidel et al., 2005). Its attachment is 
mediated by a C-terminal DCV-binding sequence (Grishanin et al., 2002). A central 
pleckstrin homology domain allows CAPS to associate at PIP-4,5- inositol 
bisphosphate-rich patches of membrane (Grishanin et al., 2004), leading to the 
suggestion that CAPS may bridge the gap between DCV and presynaptic membrane, 
tethering the vesicle at the membrane (James et al., 2008), consistent with the role of 
PIP-4,5- inositol bisphosphate in secretion (Aoyagi et al., 2005; Milosevic et al., 
2005); The presence of a MUN domain and the binding of CAPS to syntaxin (James 
et al., 2009) support a role of CAPS in SNARE complex formation. The latter is 
consistent with our results showing that CAPS facilitates priming and increases the 
RRP (Liu et al., 2008). Here we show that open-syntaxin can replace CAPS in its 
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priming function, but that Munc13-1 cannot, indicating an interdependence of these 
two proteins. These results suggest that though CAPS may seed SNARE complex 
formation, its influence on the RRP indicates that it remains associated with the 
complex to final maturation and its presence encourages maturation to the readily 
releasable state. The calcium-dependence of CAPS function can be due to intrinsic 
calcium binding, its dependence on Ca2+-dependent processes such as 
phosphoinositol-4, 5 bisphosphate formation or due to its association with 
Ca2+-modulated proteins such as Munc13. This scenario is consistent with the 
requirement for CAPS in multiple steps of the maturation of LDCVs, i.e. in 
morphological docking (Hammarlund et al., 2008), its association with syntaxin 
(Hammarlund et al., 2008; James et al., 2009) and its role in priming the RRP (Liu et 
al., 2008). 
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5. Summary 
The regulated exocytosis of neurotransmitters and many hormones occurs at 
specialized secretory complexes via Ca2+ - triggered fusion of secretory vesicles with 
the plasma membrane. The molecular machinery of neurotransmitter or hormone 
release has been the focus of intensive research. Many proteins have been isolated 
that may play a role in this highly regulated form of exocytosis. CAPS 
(calcium-activator protein for secretion) is a cytosolic protein that associates with 
large dense core vesicles and is involved in their secretion. Mammals express two 
CAPS isoforms which share a similar domain structure including a Munc13-homology 
domain (MHD) that is believed to be involved in the priming of secretory vesicles. 
Where in the secretory pathway CAPS acts is still under debate. We examined the 
secretion from CAPS-2 KO chromaffin cells which exhibit similar secretion as 
wild-type cells. We then examined secretion from chromaffin cells in which both 
CAPS genes were deleted in an attempt to discover how CAPS functions in 
regulated exocytosis.  
Deletion of both CAPS isoforms causes a strong reduction of the pool of rapidly 
releasable chromaffin granules and of sustained release during ongoing stimulation. 
The similar distribution of LDCVs in CAPS DKO and wild type cells excludes the 
possibility that suppressed secretion in CAPS DKO cells is caused by a defect in 
docking of LDCVs. Dual flash experiments indicate the recovery of RRP is greatly 
reduced but the refilling of SRP remains normal following strong secretory activity in 
CAPS DKO cells as compared to wild type cells. The calcium sensitivity of exocytosis 
and the fusion kinetics were examined by “calcium ramp” experiments and single 
spike analysis experiments respectively. Deletion of CAPS does not alter calcium 
sensing or the kinetics of single vesicle fusion during secretion.  
Either CAPS-1 or CAPS-2 can rescue secretion in cells lacking both CAPS isoforms. 
Furthermore, the deficit in the readily releasable LDCV pool upon CAPS loss is 
rescued by a constitutively open form of syntaxin, but not by Munc13-1, a priming 
protein that facilitates the conversion of syntaxin to the open conformation. We 
conclude that CAPS is required for the refilling and/or maintenance of the rapidly 
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releasable granule pool and appears to function downstream of Munc13s, a 
functional interaction between these two proteins seems to be required throughout 
the entire LDCV priming process, including the opening of syntaxin.
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